
<html lang="en"     class="pb-page"  data-request-id="a02770d5-8b41-4c1a-a22e-52e3c792b2a4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm300955x;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT6 Receptor Antagonists" /></meta><meta name="dc.Creator" content="Ramakrishna  Nirogi" /></meta><meta name="dc.Creator" content="Anil  Shinde" /></meta><meta name="dc.Creator" content="Anand  Daulatabad" /></meta><meta name="dc.Creator" content="Ramasastri  Kambhampati" /></meta><meta name="dc.Creator" content="Parandhama  Gudla" /></meta><meta name="dc.Creator" content="Mohammad  Shaik" /></meta><meta name="dc.Creator" content="Muralimohan  Gampa" /></meta><meta name="dc.Creator" content="Suresh  Balasubramaniam" /></meta><meta name="dc.Creator" content="Pamuletinarasimhareddy  Gangadasari" /></meta><meta name="dc.Creator" content="Veena  Reballi" /></meta><meta name="dc.Creator" content="Rajeshkumar  Badange" /></meta><meta name="dc.Creator" content="Kumar  Bojja" /></meta><meta name="dc.Creator" content="Ramkumar  Subramanian" /></meta><meta name="dc.Creator" content="Gopinadh  Bhyrapuneni" /></meta><meta name="dc.Creator" content="Nageswararao  Muddana" /></meta><meta name="dc.Creator" content="Pradeep  Jayarajan" /></meta><meta name="dc.Description" content="Our initial findings around aryl sulfonamide series led to N-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino)-4-methoxy benzenesulfonamide as potent and selective 5-HT6 receptor (5-HT..." /></meta><meta name="Description" content="Our initial findings around aryl sulfonamide series led to N-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino)-4-methoxy benzenesulfonamide as potent and selective 5-HT6 receptor (5-HT..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 28, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300955x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300955x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300955x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300955x" /></link>
        
    
    

<title>Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT6 Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300955x" /></meta><meta property="og:title" content="Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT6 Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0011.jpeg" /></meta><meta property="og:description" content="Our initial findings around aryl sulfonamide series led to N-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino)-4-methoxy benzenesulfonamide as potent and selective 5-HT6 receptor (5-HT6R) antagonist with reasonable pharmacokinetic properties and activity in animal models of cognition. However, lack of brain penetration and P-glycoprotein liability makes this scaffold unsuitable for further development. Our goal was to identify small molecule 5-HT6R antagonist with adequate brain penetration, acceptable ADME properties, no P-glycoprotein, and no hERG liability. Several structural modifications including bringing conformational constraint around the sulfonamide −NH group and introduction of a heteroatom to modulate the physicochemical properties were attempted. This effort culminated in the discovery of series of novel, potent, selective, orally bioavailable, and adequately brain penetrant compounds with no hERG liability. These compounds showed activity in animal models of cognition like object recognition task and water maze and in brain microdialysis studies at lower doses." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300955x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300955x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300955x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300955x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300955x&amp;href=/doi/10.1021/jm300955x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9255-9269</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300953p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300976b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT<sub>6</sub> Receptor Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramakrishna++Nirogi">Ramakrishna Nirogi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anil++Shinde">Anil Shinde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anand++Daulatabad">Anand Daulatabad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramasastri++Kambhampati">Ramasastri Kambhampati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Parandhama++Gudla">Parandhama Gudla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohammad++Shaik">Mohammad Shaik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Muralimohan++Gampa">Muralimohan Gampa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suresh++Balasubramaniam">Suresh Balasubramaniam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pamuletinarasimhareddy++Gangadasari">Pamuletinarasimhareddy Gangadasari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veena++Reballi">Veena Reballi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajeshkumar++Badange">Rajeshkumar Badange</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kumar++Bojja">Kumar Bojja</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramkumar++Subramanian">Ramkumar Subramanian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gopinadh++Bhyrapuneni">Gopinadh Bhyrapuneni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nageswararao++Muddana">Nageswararao Muddana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pradeep++Jayarajan">Pradeep Jayarajan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Discovery Research—Medicinal Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Discovery Research—In Vitro Biology, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Discovery Research—Drug Metabolism and Phamacokinetics, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Research—In Vivo Biology, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div><div class="corresp-info"><strong>*</strong>Phone: +91-40-23556038/23541142. E-mail: <a href="/cdn-cgi/l/email-protection#bdd3cbcecfd6fdcec8cbd8d393ded2d0"><span class="__cf_email__" data-cfemail="a7c9d1d4d5cce7d4d2d1c2c989c4c8ca">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300955x&amp;href=/doi/10.1021%2Fjm300955x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9255–9269</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2012</li><li><span class="item_label"><b>Published</b> online</span>28 September 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300955x" title="DOI URL">https://doi.org/10.1021/jm300955x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9255%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRamakrishna%2BNirogi%252C%2BAnil%2BShinde%252C%2BAnand%2BDaulatabad%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm300955x%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2BPiperidin-4-yl%2Bamino%2Baryl%2Bsulfonamides%253A%2BNovel%252C%2BPotent%252C%2BSelective%252C%2BOrally%2BActive%252C%2Band%2BBrain%2BPenetrant%2B5-HT6%2BReceptor%2BAntagonists%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9269%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300955x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1682</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300955x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT6 Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ramakrishna&quot;,&quot;last_name&quot;:&quot;Nirogi&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;Shinde&quot;},{&quot;first_name&quot;:&quot;Anand&quot;,&quot;last_name&quot;:&quot;Daulatabad&quot;},{&quot;first_name&quot;:&quot;Ramasastri&quot;,&quot;last_name&quot;:&quot;Kambhampati&quot;},{&quot;first_name&quot;:&quot;Parandhama&quot;,&quot;last_name&quot;:&quot;Gudla&quot;},{&quot;first_name&quot;:&quot;Mohammad&quot;,&quot;last_name&quot;:&quot;Shaik&quot;},{&quot;first_name&quot;:&quot;Muralimohan&quot;,&quot;last_name&quot;:&quot;Gampa&quot;},{&quot;first_name&quot;:&quot;Suresh&quot;,&quot;last_name&quot;:&quot;Balasubramaniam&quot;},{&quot;first_name&quot;:&quot;Pamuletinarasimhareddy&quot;,&quot;last_name&quot;:&quot;Gangadasari&quot;},{&quot;first_name&quot;:&quot;Veena&quot;,&quot;last_name&quot;:&quot;Reballi&quot;},{&quot;first_name&quot;:&quot;Rajeshkumar&quot;,&quot;last_name&quot;:&quot;Badange&quot;},{&quot;first_name&quot;:&quot;Kumar&quot;,&quot;last_name&quot;:&quot;Bojja&quot;},{&quot;first_name&quot;:&quot;Ramkumar&quot;,&quot;last_name&quot;:&quot;Subramanian&quot;},{&quot;first_name&quot;:&quot;Gopinadh&quot;,&quot;last_name&quot;:&quot;Bhyrapuneni&quot;},{&quot;first_name&quot;:&quot;Nageswararao&quot;,&quot;last_name&quot;:&quot;Muddana&quot;},{&quot;first_name&quot;:&quot;Pradeep&quot;,&quot;last_name&quot;:&quot;Jayarajan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9255-9269&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300955x&quot;},&quot;abstract&quot;:&quot;Our initial findings around aryl sulfonamide series led to N-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino)-4-methoxy benzenesulfonamide as potent and selective 5-HT6 receptor (5-HT6R) antagonist with reasonable pharmacokinetic properties and activity in animal models of cognition. However, lack of brain penetration and P-glycoprotein liability makes this scaffold unsuitable for further development. Our goal was to identify small molecule 5-HT6R antagonist with adequate brain penetration, acceptable ADME properties, no P-glycoprotein, and no hERG liability. Several structural modifications including bringing conformational constraint around the sulfonamide −NH group and introduction of a heteroatom to modulate the physicochemical properties were attempted. This effort culminated in the discovery of series of novel, potent, selective, orally bioavailable, and adequately brain penetrant compounds with no hERG liability. These compounds showed activity in animal models of cognition like object re&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300955x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300955x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300955x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300955x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300955x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300955x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300955x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300955x&amp;href=/doi/10.1021/jm300955x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300955x" /></input><a href="/doi/pdf/10.1021/jm300955x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300955x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300955x%26sid%3Dliteratum%253Aachs%26pmid%3D23006002%26genre%3Darticle%26aulast%3DNirogi%26date%3D2012%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2BPiperidin-4-yl%2Bamino%2Baryl%2Bsulfonamides%253A%2BNovel%252C%2BPotent%252C%2BSelective%252C%2BOrally%2BActive%252C%2Band%2BBrain%2BPenetrant%2B5-HT6%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9255%26epage%3D9269%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Our initial findings around aryl sulfonamide series led to <i>N</i>-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino)-4-methoxy benzenesulfonamide as potent and selective 5-HT<sub>6</sub> receptor (5-HT<sub>6</sub>R) antagonist with reasonable pharmacokinetic properties and activity in animal models of cognition. However, lack of brain penetration and P-glycoprotein liability makes this scaffold unsuitable for further development. Our goal was to identify small molecule 5-HT<sub>6</sub>R antagonist with adequate brain penetration, acceptable ADME properties, no P-glycoprotein, and no hERG liability. Several structural modifications including bringing conformational constraint around the sulfonamide −NH group and introduction of a heteroatom to modulate the physicochemical properties were attempted. This effort culminated in the discovery of series of novel, potent, selective, orally bioavailable, and adequately brain penetrant compounds with no hERG liability. These compounds showed activity in animal models of cognition like object recognition task and water maze and in brain microdialysis studies at lower doses.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s Disease International estimates that 36 million people worldwide are living with dementia, and this number is expected to increase in the future with the increased life expectancy around the globe. The worldwide costs of dementia (US$604 billion in 2010) amount to more than 1% of global GDP, according to the World Alzheimer Report 2010.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Together, these reports clearly demonstrate that Alzheimer’s disease (AD) is among the most significant social, health, and economic crises of the 21st century. The current line of treatment of AD include cholinergic (Donepezil) and glutaminergic drugs (Memantine) that have modest efficacy and poor tolerability.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Hence there is a need to discover new and effective therapeutics based on novel mechanism of action with improved efficacy and tolerability for the treatment of dementia. The 5-hydroxytryptamine-6 receptor (5-HT<sub>6</sub>R) is one such target. 5-HT<sub>6</sub>R, a GPCR, is one of the most recently identified member of serotonin (5-HT) receptor super family which is positively coupled to adenylate cyclase.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> 5-HT<sub>6</sub>R has near exclusive expression in the central nervous system (CNS).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Several psychiatric drugs have shown high affinities to this receptor.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Preclinical and clinical studies have shown that blockade of 5-HT<sub>6</sub>R function improves cognition. In addition, in vivo microdialysis studies have shown that 5-HT<sub>6</sub>R antagonism enhances neurotransmission at cholinergic and glutamatergic neurons as well as in other pathways. Thus, antagonism of the 5-HT<sub>6</sub>R can potentially provide an effective treatment for cognitive impairment in AD and schizophrenia. In the past decade, research effort in this area led to the discovery of several structurally diverse 5-HT<sub>6</sub>R agonists and antagonists (<b>1</b>–<b>7</b>)<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. These compounds have served as excellent tools to investigate the functional roles of the 5-HT<sub>6</sub>R in great detail. 4-amino-<i>N</i>-[2,6-bis(methylamino) pyrimidin-4-yl]benzenesulfonamide (Ro 04-6790, <b>1</b>) and 4-amino-<i>N</i>-[2,6-bis(methylamino)pyridin-4-yl]benzenesulfonamide (Ro 63-0563, <b>2</b>) were among the first reported 5-HT<sub>6</sub> antagonists from Roche. This was followed by the extensive work<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> of GSK scientists, which typically revolved around aryl/heteroaryl sulfonamide compounds bearing basic piperazine moiety, like 5-chloro-<i>N</i>-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-1-benzothiophene-2-sulfonamide (SB-271046, <b>3</b>). This compound was found to be moderately brain penetrant (10%), which could be the possible reason for its discontinuation from further development. Further SAR studies around SB-271046 has resulted in a highly potent and brain penetrant compound, 5-chloro-1-(3-chlorobenzenesulfonyl)-4-(piperazin-1-yl)-1<i>H</i>-indole (SB-699929, <b>4</b>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Currently two molecules from among several 5-HT<sub>6</sub>R antagonists (for which the structure is disclosed) are believed to be in active clinical development. 3-Phenylsulfonyl-8-(piperazin-1-yl)quinoline (SB-742457, <b>5</b>) from GSK is in phase II clinical trials<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> for dementia as per their product development pipeline published in February 2012. Recently, Lundbeck has reported that 2-(6-fluoro-1<i>H</i>-indol-3-yl)-<i>N</i>-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine (Lu AE58054, <b>6</b>) met its primary end point in large placebo-controlled clinical proof of concept study in people with AD.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> The progress of these diverse compounds through various phases of clinical trials will further explore the potential utility of these ligands for the treatment of AD, schizophrenia, and related cognitive disorders.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported 5-HT<sub>6</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have reported<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> our initial findings on <i>N</i>-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-(1-methyl piperidin-4-ylamino) benzenesulfonamide, <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which is a highly potent and selective 5-HT<sub>6</sub>R antagonist with moderate oral exposure and efficacy in animal models of cognition. However, the brain penetration of this lead compound <b>7</b> in male Wistar rats was found to be 0.08, indicating low brain penetration properties. This compound was also found to have P-glycoprotein liability. As we are targeting the CNS receptor, this combination of low brain penetration in rat and P-glycoprotein liability makes this scaffold unsuitable for further development, as it carries a high risk of not attaining adequate drug concentration in the brain in human clinical trials. Because our goal was to identify a small molecule 5-HT<sub>6</sub>R antagonist with adequate brain to plasma ratio and acceptable ADME properties as a possible drug-candidate for the treatment of AD, it was decided to adopt a successful strategy for improving brain penetration that involved conformational constraint with concomitant reduction in hydrogen bond count.<a onclick="showRef(event, 'cit17a cit17b cit17c'); return false;" href="javascript:void(0);" class="ref cit17a cit17b cit17c">(17a-17c)</a> In compound <b>7</b>, the “N” of the sulfonamide group was attached to an aromatic ring by a single bond, across which free rotation is possible. Once it was brought inside a ring system, the C–N free rotation gets restricted, resulting in rigidized conformation in that part of the structure. It was well documented in the literature<a onclick="showRef(event, 'cit17b'); return false;" href="javascript:void(0);" class="ref cit17b">(17b)</a> that such a conformational constraint can increase brain penetration of the molecules. Thus, this modification around sulfonamide NH of compound <b>7</b> provided us various bicyclic structures like indole, azaindole, indazole, benzoxazine, tetrahydroquinoline, tetrahydroisoquinoline, etc. (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The resultant bicyclic structures lacked the conformational freedom around sulfonamide NH as compared to compound <b>7</b>, thereby improving brain penetration. The results of these modifications covering in vitro binding affinity, pharmacokinetic, hERG affinity, and in vivo efficacy profiling constitute the subject matter of this manuscript.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Genesis of Ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of the proposed compounds <b>I</b> (e.g., compound <b>12</b>) and compounds <b>II</b> (e.g., compounds <b>18</b> and <b>19</b>) was achieved as shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, respectively. Substituted indoles <b>8</b> were treated with commercially available substituted 3-nitrobenzenesulfonyl chlorides <b>9</b> in the presence of triethylamine or pyridine as base to afford (3-nitro-4-substituted phenylsulfonyl)-1<i>H</i>-indoles <b>10</b>. Reduction of <b>10</b> was carried out with Fe-HCl under reflux to obtain (3-amino-4-substituted phenylsulfonyl)-1<i>H</i>-indoles <b>11</b>. The latter compounds <b>11</b> were reacted with 1-methyl-4-piperidone in the presence of acetic acid, sodium sulfate, and sodium triacetoxyborohydride to afford targeted compounds <b>12</b>. Aromatic heterocycles <b>13</b> were reacted with 4-substituted-3-trifluoroacetamido benzenesulfonyl chloride <b>14</b> in the presence of sodium hydride as base, yielding <b>15</b>. Hydrolysis of <b>15</b> with concentrated HCl in ethanol under reflux yielded compounds <b>16</b>. 1-Methyl-4-piperidone was reacted with <b>16</b> in presence of acetic acid, sodium sulfate, and sodium triacetoxyborohydride to obtain the targeted compounds <b>18</b>. 1-Boc-4-piperidone was reacted with <b>16</b> under reductive amination conditions to obtain Boc protected intermediates <b>17</b>. These on deprotection with IPA·HCl yielded targeted compounds <b>19</b> as HCl salts (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, DCM, 0–5 °C to RT, 24–48 h or DCM, pyridine, RT, 24–48 h; (b) HCl/Fe, ethanol, reflux, 2–10 h; (c) 1-methyl-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/NaH, 0–25 °C, 12–24 h, or DCM, Et<sub>3</sub>N, RT or pyridine, RT; (b) ethanol, conc HCl, reflux, 2–10 h; (c) 1-Boc-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h; (d) IPA·HCl, RT, 2–4 h; (e) 1-methyl-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h. For definition of Het, see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have synthesized a series of novel indole sulfonamides, i.e., compounds <b>I</b> (<b>12a</b>–<b>12ad</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and compounds <b>II</b> (<b>18a</b>–<b>18s</b> and <b>19a</b>–<b>19e</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). All the synthesized compounds were evaluated in a reporter gene based assay<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> for their functional activity at 5-HT<sub>6</sub>R. In short, the assay uses a stable CHO cell line expressing recombinant human 5-HT<sub>6</sub>R and pCRE-Luc reporter system which refers a nonradioactive-based approach to determine the binding of a compound to GPCRs. The <i>K</i><sub>b</sub> and <i>I</i><sub>max</sub> (%) values of these compounds are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Compounds I<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>b</sub>(nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>I</i><sub>max</sub>(%)</th><th class="colsep0 rowsep0" align="center" char=".">CLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.31</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.39 ± 0.28</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">3.19 ± 0.27</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.42</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 1.59</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.14</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">6-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.39 ± 0.55</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">5-Br</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.91 ± 0.43</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">5-Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">10.3 ± 2.05</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">5-Br</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">16.02 ± 4.94</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">7.5 ± 1.41</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">18.3 ± 4.03</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.80 ± 0.14</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="char" char="±">12.80 ± 3.82</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4.37 ± 0.82</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">3.80 ± 0.56</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">51.30 ± 16.26</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">11.70 ± 2.50</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12t</b></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">12.50 ± 2.41</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12u</b></td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12v</b></td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12w</b></td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">3.30 ± 1.06</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12x</b></td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.28</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12y</b></td><td class="colsep0 rowsep0" align="left">5-OCH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.56</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12z</b></td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aa</b></td><td class="colsep0 rowsep0" align="left">5-F, 3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.52 ± 0.26</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">4.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ab</b></td><td class="colsep0 rowsep0" align="left">5-Cl, 3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">4.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ac</b></td><td class="colsep0 rowsep0" align="left">6-Cl, 3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ad</b></td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub>, 3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The compounds were tested in vitro with nonradioactive-based approach for determination of <i>K</i><sub>b</sub> values with cell-based assay for 5-HT<sub>6</sub>R. Values are the average of at least two independent experiments. Compounds <b>12g</b>, <b>12h</b>, and <b>12w</b> were tested as hydrochloride salts, while <b>12u</b>, <b>12v</b>, and <b>12x</b> were tested as phosphate salts. Rest of the compounds were tested as free bases.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Compounds <b>II</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0010.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Het</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>b</sub>(nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>I</i><sub>max</sub>(%)</th><th class="colsep0 rowsep0" align="center" char=".">CLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4 ± 0.71</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.78</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.04 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">3.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.42</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18e</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.56</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18f</b></td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18g</b></td><td class="colsep0 rowsep0" align="left">E</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">12 ± 2.82</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18h</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.69</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18i</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.14</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18j</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 2.82</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18k</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">28.6 ± 6.12</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18l</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.14</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18m</b></td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.014</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18n</b></td><td class="colsep0 rowsep0" align="left">L</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.015</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18o</b></td><td class="colsep0 rowsep0" align="left">J</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.013</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18p</b></td><td class="colsep0 rowsep0" align="left">K</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.014</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18q</b></td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.014</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18r</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18s</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">P</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.098</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">Q</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.74</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.014</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The compounds were tested in vitro with nonradioactive-based approach for determination of <i>K</i><sub>b</sub> values with cell-based assay for 5-HT<sub>6</sub>R. Values are the average of at least two independent experiments. Compounds <b>18a</b>, <b>18b</b>, <b>18e</b>, <b>18f</b>, <b>18h</b>, <b>18i</b>, and <b>18j</b> were tested as <span class="smallcaps smallerCapital">l</span>-(+)-tartarate salts. <b>19a</b>, <b>19b</b>, <b>19c</b>, <b>19d</b>, and <b>19e</b> were tested as hydrochloride salts. Rest all were tested as free bases.</p></div></div></div><div class="NLM_p">We have initiated our initial SAR studies with commercially available unsubstituted indole. Several modifications (<b>12a</b>–<b>12d</b>) were attempted to arrive at the optimum substitution at R<sup>2</sup>. All the synthesized compounds (<b>12a</b>–<b>12d</b>) were found to have potent in vitro affinity toward 5-HT<sub>6</sub>R, indicating that conformational constraint in compound <b>7</b> was well tolerated for binding affinity. With no clear preference to R<sup>2</sup> substitution in unsubstituted indole, we ran halo scan around indole nucleus by keeping R<sup>2</sup> as methoxy. Both 6-Cl and 5-Cl indole substituted compounds (<b>12e</b> and <b>12p</b>) were found to have potent 5-HT<sub>6</sub>R affinity. However, <b>12e</b> has clear preference over <b>12p</b> in terms of affinity with <i>K</i><sub>b</sub> of 0.14 nM. Replacement of methoxy group (<b>12e</b>) with ethyl (<b>12f</b>) and hydrogen (<b>12h</b>) at the R<sup>2</sup> position gave less potent compounds as compared to <b>12e</b>. Compounds <b>12n</b> and <b>12g</b> with 5-F and 6-F indole were also active. Compound <b>12i</b> (<i>K</i><sub>b</sub> = 1.91 nM) with 5-Br indole substitution was equipotent to <b>12n</b>.</div><div class="NLM_p">The other substitutions evaluated on indole ring include alkoxy groups (viz. OMe, OiPr) at 5 and 6 positions. Both 5-OMe and 6-OMe compounds were potent in terms of in vitro affinity. The most potent compound was <b>12u</b> (<i>K</i><sub>b</sub> = 0.1 nM), having 6-OMe indole and R<sup>2</sup> = OMe. It was observed that, there was considerable increase in potency after moving the −OMe group from fifth position of indole (<b>12q</b>, <i>K</i><sub>b</sub> = 3.80 nM) to the sixth position of indole (<b>12u</b>, <i>K</i><sub>b</sub> = 0.1 nM), indicating the preference for substitution at sixth position. A similar trend was observed with halo substitution as well (compare <b>12n</b> and <b>12g</b>). Generally, all 6-OMe indole analogues have shown potent 5-HT<sub>6</sub>R affinities (<b>12u</b>–<b>12x</b>), with <i>K</i><sub>b</sub> in the range of 0.1–3.3 nM. In the 5-OMe indole series, when R<sup>2</sup> was changed from −OMe (<b>12q,</b><i>K</i><sub>b</sub> = 3.8 nM) to other substitutions like Me, F, and H (<b>12r</b>, <b>12s</b>, and <b>12t</b> with <i>K</i><sub>b</sub> = 51.3, 11.7, 12.5 nM respectively), there was nearly 3–10-fold decrease in potency. Compound with 5-OiPr substitution on indole (<b>12y</b>, <i>K</i><sub>b</sub> = 2.2 nM) was also found to be active like its analogue, with 5-OMe substitution on indole (<b>12q</b>, <i>K</i><sub>b</sub> = 3.8 nM), indicating that higher alkoxy group was also well tolerated. 3-Me indole analogue <b>12z</b> was found to be 3-fold more potent (<i>K</i><sub>b</sub> = 0.52 nM) compared to compound <b>12d</b> (R<sup>1</sup> = H, <i>K</i><sub>b</sub> = 1.6 nM). In 5-bromo indole compound (<b>12i</b>, <i>K</i><sub>b</sub> = 1.91 nM), replacement of methoxy at R<sup>2</sup> position with −H (<b>12j</b> with <i>K</i><sub>b</sub> = 10.3 nM) and −F (<b>12k</b> with <i>K</i><sub>b</sub> = 16.02 nM) gave less potent compounds. In 5-fluoro indole compound <b>12n</b> (<i>K</i><sub>b</sub> = 1.8 nM), when R<sup>2</sup> was replaced with lower alkyls viz. −Me (<b>12l,</b><i>K</i><sub>b</sub> = 7.5 nM) and −Et (<b>12 m,</b><i>K</i><sub>b</sub> = 18.3 nM), gave compounds which were 4–10-fold less potent than <b>12n</b>. In compounds <b>12f</b> and <b>12o</b>, where R<sup>2</sup> was −Et, the 6-chloro indole <b>12f</b> (<i>K</i><sub>b</sub> = 5.3 nM) was almost 3-fold more potent compared to 4-chloro indole <b>12o</b> (<i>K</i><sub>b</sub> = 12.8 nM). Most of the compounds, with diverse substitutions on indole, were active toward 5-HT<sub>6</sub>R, with few exceptions (viz. <b>12k</b>, <b>12m</b>, <b>12r</b>, and <b>12t</b> with <i>K</i><sub>b</sub> values 16.02, 18.3, 51.3, and 12.5 nM, respectively). Some disubstituted indoles, such as 5-halo-3-methyl, 6-halo-3-methyl, and 6-alkoxy-3-methyl indoles (<b>12aa</b>–<b>12ad</b>) were also prepared for SAR studies. In general, all the synthesized compounds were found to have very potent binding affinities toward 5-HT<sub>6</sub>R, with <i>K</i><sub>b</sub> < 4 nM. The 5-chloro-3-methyl indole analogue <b>12ab</b> (<i>K</i><sub>b</sub> < 0.02 nM) was found to be the most potent analogue belonging to compounds <b>I</b>. The desmethyl analogues <b>19a</b>–<b>19c</b> (R<sup>2</sup> = H, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) of <b>12g</b>, <b>12i</b>, and <b>12n</b>, respectively, were found to have potent in vitro affinities with <i>K</i><sub>b</sub> values of 0.3, 3.2, and 0.3 nM, respectively. Because most of the modifications around indole nucleus gave us potent compounds, we did not make any further attempt to synthesize any additional analogues. As our main goal was to identify a potent 5-HT<sub>6</sub>R antagonist with adequate brain penetration, we have selected one of the most potent compounds each from mono (<b>12u</b>) and disubstituted (<b>12ab</b>) indoles for testing their brain penetration properties in the rat. The brain penetration ratio (<i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub>) was found to be 0.6 ± 0.59 and 4.3 ± 0.9 for compounds <b>12u</b> and <b>12ab</b>, respectively, when dosed orally. Having achieved good brain penetration for <b>12ab</b>, we then tested this compound for its target selectivity (serotonin subtypes, dopaminergic, transporters, α<sub>1B</sub>, histamine H<sub>1</sub>, etc.). The data, which is given in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, indicate no major selectivity concerns over the tested receptors. Compound <b>12ab</b> had acceptable in vitro metabolic stability in both human (0% metabolized) and rat (40% metabolized) liver microsomes at 30 min. The IC<sub>50</sub> values for CYP 2D6 and CYP 3A4 were found to be 14.7 and 6.46 μM, respectively, indicating less likely potential for drug–drug interactions in humans through the major metabolic enzymes tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CYP P450 Inhibition and Microsomal Metabolic Stability Data for Selected Compounds<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">surrogate % metabolism at 30 min</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">Wistar rat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ab</b></td><td class="colsep0 rowsep0" align="center">14.70</td><td class="colsep0 rowsep0" align="center">6.46</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="center">>45</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18i</b></td><td class="colsep0 rowsep0" align="center">14.5</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18m</b></td><td class="colsep0 rowsep0" align="center">27</td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The CYP P450 inhibitory potential was determined using isoform-selective assays using human liver microsomes. These values are the mean of duplicate determinations. Microsomal metabolic stability was performed at 30 min incubations in Wistar rat and Human (2.5 μM).</p></div></div></div><div class="NLM_p">In the rat pharmacokinetic experiment (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), <b>12ab</b> showed acceptable pharmacokinetic properties (<i>C</i><sub>max</sub> = 296 ± 104 ng/mL, <i>t</i><sub>1/2</sub> = 2.2 ± 0.8 h) and oral bioavailability (<i>F</i> = 75 ± 38%).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic and Brain Penetration Profile of Selected Compounds in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">rat<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">dog<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>12ab</b></th><th class="colsep0 rowsep0" align="center"><b>18i</b></th><th class="colsep0 rowsep0" align="center"><b>18m</b></th><th class="colsep0 rowsep0" align="center"><b>18c</b></th><th class="colsep0 rowsep0" align="center"><b>18c</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Intravenous</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–24</sub>(ng·h/mL)</td><td class="colsep0 rowsep0" align="left">2756 ± 375</td><td class="colsep0 rowsep0" align="left">600 ± 164</td><td class="colsep0 rowsep0" align="left">1448 ± 175</td><td class="colsep0 rowsep0" align="left">1311 ± 249</td><td class="colsep0 rowsep0" align="left">1402 ± 479</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub><b>1/2</b></sub> (h)</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.8</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vz (L/kg)</td><td class="colsep0 rowsep0" align="left">11 ± 2</td><td class="colsep0 rowsep0" align="left">16 ± 5</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">59 ± 8</td><td class="colsep0 rowsep0" align="left">143 ± 41</td><td class="colsep0 rowsep0" align="left">58 ± 7</td><td class="colsep0 rowsep0" align="left">64 ± 13</td><td class="colsep0 rowsep0" align="left">12 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Oral</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">296 ± 104</td><td class="colsep0 rowsep0" align="left">57 ± 19</td><td class="colsep0 rowsep0" align="left">197 ± 240</td><td class="colsep0 rowsep0" align="left">156 ± 61</td><td class="colsep0 rowsep0" align="left">549 ± 69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.67 ± 0.58</td><td class="colsep0 rowsep0" align="left">2.0 ± 0</td><td class="colsep0 rowsep0" align="left">0.50 ± 0</td><td class="colsep0 rowsep0" align="left">1.0 ± 0</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–24</sub>(ng·h/mL)</td><td class="colsep0 rowsep0" align="left">2091 ± 1266</td><td class="colsep0 rowsep0" align="left">300 ± 90</td><td class="colsep0 rowsep0" align="left">384 ± 425</td><td class="colsep0 rowsep0" align="left">389 ± 143</td><td class="colsep0 rowsep0" align="left">3631 ± 203</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">75 ± 38</td><td class="colsep0 rowsep0" align="left">25 ± 2</td><td class="colsep0 rowsep0" align="left">12 ± 12</td><td class="colsep0 rowsep0" align="left">29 ± 5</td><td class="colsep0 rowsep0" align="left">92 ± 25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b</sub>/<i>C</i><sub>p</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Fasted male Wistar rats, water was used as a vehicle for dose formulation preparation; 10 mL/kg for oral and 2 mL/kg for intravenous was used as dosing volume.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Fasted male Beagle dogs, water was used as a vehicle for dose formulation preparation; 1 mL/kg was used as a dosing volume. Values are mean ± SD; <i>N</i> = 3 animals/route. NA: not applicable.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Discrete brain penetration was performed in rats at 10 mg/kg at 1 h after oral administration.</p></div></div></div><div class="NLM_p">Compound <b>12ab</b> was evaluated for its procognitive potential using a rat model of cognition, i.e., object recognition task.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compound <b>12ab</b> reversed the time delay induced memory deficit, and the effect reached statistical significance at 3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This compound was further tested in 7 day repeated dose oral toxicity in rats to determine its safety. The compound exhibited phospholipidosis type of changes in multiple organs. The possible reason could be the high lipophilic nature<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> of the compound <b>12ab</b> (CLogP = 4.95, Cambridge Chemoffice software), which drive high tissue distribution inducting phospolipidosis. Later, <b>12ab</b> was found to have hERG liability (<i>K</i><sub>i</sub> = 800 nM). The phospholipidosis type of changes in multiple organs and hERG data makes this compound in particular and the scaffold in general less suitable for further development.<div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity Data<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>12ab</b></th><th class="colsep0 rowsep0" align="center"><b>18c</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>6</sub><i>K</i><sub>b</sub> (nM)</td><td class="colsep0 rowsep0" align="center">0.02</td><td class="colsep0 rowsep0" align="center">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">536</td><td class="colsep0 rowsep0" align="center">2374</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2C</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">3124</td><td class="colsep0 rowsep0" align="center">2243</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>7</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">6371</td><td class="colsep0 rowsep0" align="center">1956</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">302.6</td><td class="colsep0 rowsep0" align="center">1812</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>1</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">681.8</td><td class="colsep0 rowsep0" align="center">586</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α<sub>1b</sub><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">955.4</td><td class="colsep0 rowsep0" align="center">3791</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERT <i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">1942</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DOPT <i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">2899</td><td class="colsep0 rowsep0" align="center">3221</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NORT <i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="center">2006</td><td class="colsep0 rowsep0" align="center">2129</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>4</sub> EC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>3</sub> IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub> EC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="center">>1000</td><td class="colsep0 rowsep0" align="center">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values are the average of at least two independent experiments.</p></div></div></div></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Episodic memory in adult rats for <b>12ab</b>. Data represents mean ± SEM of exploration time (Students paired <i>t</i> test, **<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hence the next set of modifications were then targeted around compound <b>12ab</b> so as to get rid of the toxicity and hERG liability of this series while maintaining adequate levels of brain penetration. To achieve this goal, we thought of replacing indole with several other bicyclic heterocycles like azaindole, indazole, benzoxazine, tetrahydroquinoline, and tetrahydroisoquinoline (compounds <b>II</b>). Several analogues were synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Initially, three analogues prepared with 5-chloro-3-methyl-7-azaindole as Het (<b>18a</b>–<b>18c</b>) were found to maintain the potent binding affinity. However, among them, as expected, <b>18c</b> (<i>K</i><sub>b</sub> = 0.04 nM), which is an azaindole analogue of <b>12ab</b> was found to maintain a similar potency as that of <b>12ab</b>. Other regioisomers of <b>18c</b> were also prepared. Compound <b>18d</b> and <b>18e</b> with Het = 5-chloro-3-methyl-6-azaindole and 5-chloro-3-methyl-4-azaindole, respectively, as central core were found to be >30-fold less potent compared to <b>18c</b>. Compound <b>18h</b> with Het = 5-methoxy-3-methyl-7-azaindole was found to be ∼60-fold less potent compared to <b>18c</b>. Its close analogue, <b>18g</b> with Het = 5-methoxy-7-azaindole, was found to be ∼6-fold less potent as compared to <b>18h</b>. Compound <b>18f,</b> where Het is 5-chloro-7-azaindole, was found to have almost equipotent activity as that of <b>18c</b>. We then next turned our attention to indazole type of compounds. Three analogues were prepared (<b>18i</b>–<b>18k</b>) where changes were made at R<sup>1</sup>. Out of these compounds, <b>18i</b> was found to possess good in vitro potency for 5-HT<sub>6</sub>R with <i>K</i><sub>b</sub> of 0.6 nM. We then introduced Het = variously substituted 2,3-dihydro-benzo[1,4]oxazine ring system and synthesized compounds <b>18l</b>–<b>18q</b>. All these compounds were found to have potent in vitro activity, with <i>K</i><sub>b</sub> in the range of 0.1–0.2 nM. Compounds with tetrahydroquinoline (<b>18r</b>) and tetrahydroisoquinoline (<b>18s</b>) moieties were also found to maintain the in vitro potency with <i>K</i><sub>b</sub> < 0.1 nM. Compounds <b>19d</b>, <i>K</i><sub>b</sub> = 0.1 nM, and <b>19e</b>, <i>K</i><sub>b</sub> = 0.1 nM, which might be the possible metabolites of compounds <b>18c</b> and <b>18r</b>, respectively, maintained the functional activity toward 5-HT<sub>6</sub>R, indicating secondary amines were also well tolerated.</div><div class="NLM_p">Compounds <b>18c</b>, <b>18i</b>, <b>18m</b>, <b>18r</b>, and <b>18s</b>, which are the most potent compounds and represent major changes brought about in compounds <b>II</b>, were selected for brain penetration study to confirm that these structural modifications maintain the brain penetration. <b>18r</b> and <b>18s</b> were found to have <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> ratio of 0.02 and 0.24, respectively, and thus were not profiled further. On the basis of the adequate brain penetration ratio of <b>18c</b> (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> = 0.9), <b>18i</b> (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> = 0.5), and <b>18m</b> (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> = 0.6), these three compounds were subjected to ADME surrogate assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and preclinical pharmacokinetic profiling (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). All these compounds were moderately metabolized in human and rat liver microsomes, and the CYP 3A4 and 2D6 inhibition values were found to be >10 μM except for <b>18m</b>. The pharmacokinetic studies conducted in rats for compound <b>18c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) showed acceptable oral exposure (<i>C</i><sub>max</sub> = 156 ± 61 ng/mL) and iv half-life of 1.7 ± 0.1 h, with oral bioavailability of 29 ± 5%. Good oral bioavailability was observed in Beagle dogs as well (92 ± 25%) for compound <b>18c</b>, with adequate oral exposure (<i>C</i><sub>max</sub> = 549 ± 69 ng/mL) and iv half-life of 2.3 ± 0.8 h. The total clearance, after intravenous administration was high in rats and low in dog for <b>18c</b>. The brain penetration of <b>18c</b> in rat was on a lower side (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> = 0.9 ± 0.3) compared to that of compound <b>12ab</b> (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> = 3.8 ± 0.2), possibly because of the polar nature of <b>18c</b> compared to <b>12ab</b>. We did not profile <b>18i</b> further because of its low oral exposure (<i>C</i><sub>max</sub> = 57 ± 19 ng/mL) and high clearance (143 ± 41 mL/min/kg) and <b>18m</b> because of its poor bioavailability.</div><div class="NLM_p">Given the hERG concern with compounds <b>I</b>, we have tested highly potent and selective compounds <b>II</b> for their hERG affinity by radioligand binding assay. In both series I and II compounds, we have observed a good correlation between hERG <i>K</i><sub>i</sub> value and the theoretical ClogP value. More the lipophilic nature of a compound, the stronger is its hERG inhibitory activity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Lipophilic compounds <b>12aa</b> and <b>12ab</b> with ClogP of 4.38 and 4.95, respectively, showed potent hERG inhibitory values of 950 and 800 nM. More polar compounds <b>18c</b> (ClogP = 3.79), <b>18i</b> (ClogP = 2.36), and <b>18l</b> (ClogP = 2.83) showed significantly lower inhibitory activities at the hERG channel with <i>K</i><sub>i</sub> >10 μM. The adequate <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> ratio, good pharmacokinetic profile in rat and dog, and no hERG concern for <b>18c</b> has prompted us to subject this compound for detailed pharmacological profiling. In the rats object recognition task,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compound <b>18c</b> reversed the time delay induced memory deficit, and the effect reached statistical significance at doses ranging from 1–10 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Acetylcholine (ACh) modulation in medial prefrontal cortex was evaluated after subcutaneous administration of compound <b>18c</b> in Wistar rats using brain microdialysis.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Acute administration of compound <b>18c</b> (3 and 10 mg/kg) increased extracellular ACh in medial prefrontal cortex in a dose dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), and the significant increase (<i>p</i> > 0.05) was observed at 10 mg/kg compared to vehicle treated animals. Procognitive properties of <b>18c</b> were mediated through increase in cortical ACh levels in preclinical species.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Episodic memory in adult rats for <b>18c</b>. Data represents mean ± SEM of exploration time (Students paired <i>t</i> test, *<i>P</i> < 0.05, **<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>18c</b> on acetylcholine modulation in medial prefrontal cortex. Data expressed mean ± SEM *<i>p</i> < 0.05, **<i>p</i> < 0.01,***<i>p</i> < 0.001 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Thus, starting from low brain penetrant compound <b>7</b>, through an iterative cycle, we have identified novel series of compounds <b>I</b> and <b>II</b> which are highly potent, selective, brain penetrant, and active in animal models of cognition. The correlation between the lipophilicity and hERG is reported for both the series of compounds. On the basis of its overall profile, compound <b>18c</b> was selected for further development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p last">All the reagents and chemicals used were of “reagent grade”. Substituted indoles <b>8</b> (substituted indoles were either commercially procured or synthesized according to literature methods),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Aromatic heterocycles <b>13</b> (5-chloroindazole, 5-chloro-7-aza-indole, tetrahydroquinoline, and tetrahydroisoquinoline) were commercially procured, whereas 5-chloro-4-azaindole, 5-chloro-6-azaindole, and benzo[1,4]oxazine derivatives were synthesized according to literature methods.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thin layer chromatography (TLC) was performed on Merck silica gel 60 F<sub>254</sub> plates, and spots visualization was accomplished with UV light (254 nm) and/or iodometry. Chromatography refers to column chromatography performed using 60–120 mesh silica gel and executed under nitrogen pressure (flash chromatography) conditions. All the mentioned yields refer to isolated pure products. Melting points of synthesized compounds were determined using Electro thermal (model IA 9300 series) open capillary apparatus and are uncorrected. Infrared spectra were recorded on KBr disk and in solid state using Perkin-Elmer model 1600 FT-IR spectrophotometer (Perkin-Elmer, Norwalk, CT, USA). Electrospray ionization mass spectra were recorded on API 4000 triple quadrupole instrument (MDS-SCIEX, Concord, Ontario, Canada). <sup>1</sup>H NMR spectra were obtained on a Bruker NMR spectrometer (Fallanden, Switzerland) at 400 MHz. Deuterated reagents were used as solvents and were commercially procured. Tetramethylsilane (TMS) was used as an internal standard. Chemical shift values were expressed in parts per million (δ), and coupling constants were expressed in Hz. Purity of the final compounds (>95%) was established using Agilent 1100 high-performance liquid chromatography (HPLC) system equipped with (i) XBridge column, 150 mm × 4.6 mm, S-5 μm, with detection at 220 nm, using a UV–visible detector; flow rate = 1 mL/min; column temperature 30 °C, gradient elution over a run time of 35 min, using buffer–acetonitrile (buffer: 50 mM HCOONH<sub>4</sub>, adjusted to pH 9.0 with aqueous NH<sub>3</sub>) and compounds <b>18a</b>, <b>18d</b>, <b>18e</b>, <b>18l</b>, <b>18m</b>, <b>18n</b>, <b>18p</b>, and <b>18q</b> were tested using this method. (ii) YMC-pack-ODS-AM column, 250 mm × 4.6 mm, S-5 μm, with detection at 220 nm, using a UV–visible detector; flow rate = 1 mL/min; column temperature 30 °C, gradient elution over a run time of 35 min, using buffer–acetonitrile (buffer: 0.05% Et<sub>3</sub>N in water, adjusted to pH 2.5 with CF<sub>3</sub>COOH), and compounds <b>12a</b>–<b>12ad</b>, <b>18r</b>, <b>18s</b>, <b>19a</b>–<b>19c</b>, and <b>19e</b> were tested using this method. (iii)YMC-pack-ODS-AM column, 250 mm × 4.6 mm, S-5 μm, with detection at 220 nm, using a UV–visible detector; flow rate = 1 mL/min; column temperature 30 °C, gradient elution over a run time of 35 min, using buffer: acetonitrile (buffer–5 mM CH<sub>3</sub>COONH<sub>4</sub> in water, adjusted pH to 3.0 with HCOOH), and compounds <b>18b</b>, <b>18c</b>, <b>18f</b>, <b>18g</b>, <b>18h</b>, <b>18i</b>, <b>18j</b>, <b>18k</b>, <b>18o</b>, and <b>19d</b> were tested using this method.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedures (<b>10</b>, <b>11</b>, <b>12a</b>–<b>12ad</b>)</h3><div class="NLM_p">The substituted indoles (<b>8</b>, 1 mmol) were reacted with commercially procured 4-substituted-3-nitrobenzenesulfonyl chlorides (<b>9</b>, 2 mmol) in the presence of triethylamine (3 mmol) and dichloromethane. The reaction mass was stirred at rt for 24–48 h. After completion of the reaction (TLC), the reaction mass was diluted with water and extracted with dichloromethane. The organic layer was washed with brine solution, dried over sodium sulfate, and concentrated under reduced pressure to obtain nitro intermediates <b>10</b> as residual mass which were used as such in the next step without purification.</div><div class="NLM_p">The nitro intermediate (<b>10</b>, 1 mmol), thus obtained, was added to a stirred mixture of iron powder (10 mmol), ethanol–water (8:2) and conc HCl (5 mmol). The reaction mass was heated at reflux for 2–10 h. After completion of the reaction (TLC), the reaction mass was filtered through Celite bed and solvent was removed under reduced pressure to obtain a thick syrupy mass. The mass was diluted with excess of water, basified with aqueous sodium carbonate, and extracted the product with ethyl acetate. The organic layer was washed with brine solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a syrupy mass, which was purified by flash column chromatography using ethyl acetate–hexane (1:1) as eluent to obtain amine intermediates <b>11</b>. These amine intermediates <b>11</b> (1 mmol) were treated with 1-methyl-4-piperidone (3 mmol), sodium triacetoxyborohydride (3 mmol), and sodium sulfate (10 mmol) in acetic acid. The reaction mass was stirred for 6–24 h. After completion of the reaction (TLC), the reaction mass was poured onto water, neutralized with 40% sodium hydroxide solution (pH ∼ 12), and extracted with dichloromethane. The organic layer was washed with brine solution, dried over sodium sulfate, and concentrated under reduced pressure to obtain a syrupy mass, which was purified by flash column chromatography using ethyl acetate–hexanes (8:2) as eluent to obtain the targeted compounds <b>12</b>.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 1-(3-Nitro-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-indole (<b>10</b>, R<sup>1</sup> = 5-Cl, 3-CH<sub>3</sub>, R<sup>2</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p last">3-Nitro-4-methoxybenzenesulfonyl chloride (15.2 g, 60.6 mmol) was added to a stirred solution of 5-chloro-3-methyl indole (5 g, 30.3 mmol), DCM (100 mL), and triethylamine (12.6 mL, 90.9 mmol), and the mass was further stirred for 24 h at room temperature. After completion of the reaction (TLC), the mixture was poured onto water (100 mL), the organic layer separated, dried over sodium sulfate, and concentrated under vacuum to obtain residual oil (crude). ESI mass: <i>m</i>/<i>e</i> 381 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 1-(3-Amino-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-indole (<b>11</b>, R<sup>1</sup> = 5-Cl, 3-CH<sub>3</sub>, R<sup>2</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p last">Concentrated hydrochloric acid (6.7 mL, 65.8 mmol) was added to a stirred solution of 1-(3-nitro-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-indole (<b>10</b>, 5 g, 13 mmol), iron powder (3.7 g, 65.8 mmol), and ethanol–water (40 mL:10 mL) mixture. The mixture was refluxed for 3 h. After completion of the reaction (TLC), the mixture was cooled to room temperature and removed solvent under vacuum. The residual mass was stirred with water (100 mL) and ethyl acetate (100 mL) for 15 min. The organic layer was separated, dried over anhydrous sodium sulfate, and concentrated in vacuo. The resultant residual mass was chromatographed (silica gel, 2:8 to 1:1 ethyl acetate–hexanes as eluent) to obtain the title compound as brown solid (2.5 g, 54% yield). IR (cm<sup>–1</sup>): 3480, 3384, 1286, 1167. ESI mass: <i>m</i>/<i>e</i> 351 (M + H)<sup>+</sup>; MR (°C): 139–141. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 2.20 (s, 3H), 3.83 (s, 3H), 4.01 (bs, 2H), 6.73–6.70 (d, <i>J</i> = 8.50 Hz, 1H), 7.06 (d, <i>J</i> = 2.27 Hz, 1H), 7.23–7.29 (m, 3H), 7.40–7.41 (d, <i>J</i> = 1.96 Hz, 1H), 7.87–7.89 (d, <i>J</i> = 8.78 Hz, 1H), 7.50–7.53 (m, 2H), 8.01–8.03 (d, <i>J</i> = 8.20 Hz, 1H). HPLC purity: 98.9%.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure for the Preparation of Phosphate Salt</h3><div class="NLM_p">The compounds <b>12</b> (1 mmol) were treated with <i>ortho</i>-phosphoric acid (2 mmol) in dichloromethane–IPA (2:8) and stirred for 2 h at 25–30 °C. The solids that separated were filtered and dried under reduced pressure to obtain the phosphate salt.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-indole (<b>12ab</b>, R<sup>1</sup> = 5-Cl, 3-CH<sub>3</sub>, R<sup>2</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p">Sodium triacetoxyborohydride (4.33 g, 20.55 mmol) was added in portions to a stirred suspension of 1-(3-amino-4-methoxy benzenesulfonyl)-1<i>H</i>-5-chloro-3-methyl indole (2.4 g, 6.85 mmol), 1-methyl-4-piperidone (2.3 g, 20.55 mmol), and sodium sulfate (9.7 g, 68.5 mmol) in glacial acetic acid (30 mL) at room temperature under N<sub>2</sub> atmosphere. The mass was stirred overnight at room temperature. After completion of the reaction (TLC), the mixture was poured onto cold water, neutralized with aq NaOH solution, and extracted with ethyl acetate (3 × 75 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to obtain an oily residue. The mass was chromatographed (neutral silica gel, 80:20 ethyl acetate–hexanes, and then ethyl acetate) to afford the title product as pale-yellow solid (1.8 g, 60% yield). IR (cm<sup>–1</sup>): 3427, 2935, 1359, 1165, 1126. ESI mass: <i>m</i>/<i>e</i> 448 (M + H)<sup>+</sup>. MR (°C): 141–144. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.36–1.45 (m, 2H), 1.84–1.87 (m, 2H), 2.08–2.13 (m, 2H), 2.19 (s, 3H), 2.32 (s, 3H), 2.77–2.80 (m, 2H), 3.13–3.15 (m, 1H), 3.82 (s, 3H), 4.21–4.23 (d, 1H), 6.65–6.67 (d, <i>J</i> = 8.44 Hz, 1H), 6.78–6.79 (d, <i>J</i> = 2.20 Hz, 1H), 7.13–7.16 (dd, <i>J</i> = 8.40, 2.28 Hz, 1H), 7.23–7.28 (m, 2H), 7.40 (d, <i>J</i> = 1.92 Hz, 1H), 7.93–7.95 (d, <i>J</i> = 8.80 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 9.47, 31.85, 46.16, 54.34, 55.58, 106.15, 108.43, 114.79, 115.57, 117.64, 119.0, 124.39, 124.70, 128.61, 130.05, 132.94, 133.85, 137.12, 150.40. HPLC purity: 99%.</div><div class="NLM_p last">Compounds <b>12a</b>–<b>12aa</b> and <b>12ac</b>–<b>12ad</b> were prepared analogously.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-1<i>H</i>-indole (<b>12a</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3412, 2937, 1267, 1165. ESI mass: <i>m</i>/<i>e</i> 400 (M + H)<sup>+</sup>. MR (°C): 140–142. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.35–1.44 (m, 2H), 1.85–1.89 (m, 2H), 2.08–2.14 (m, 2H), 2.31 (s, 3H), 2.75–2.78 (m, 2H), 3.15–3.20 (m, 1H), 3.80 (s, 3H), 4.20–4.22 (d, 1H), 6..61–6.62 (d, <i>J</i> = 3.60 Hz, 1H), 6.65–6.67 (d, <i>J</i> = 8.48 Hz, 1H), 6.86–6.87 (d, <i>J</i> = 2.24 Hz, 1H), 7.18–7.28 (m, 3H), 7.50–7.53 (m, 2H), 8.01–8.03 (d, <i>J</i> = 8.20 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-ethylbenzenesulfonyl]-1<i>H</i>-indole (<b>12b</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3429, 2939, 2783, 1519, 1440, 1367, 1267, 1166, 1132. MR (°C): 144–145. ESI mass: <i>m</i>/<i>e</i> 398 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.15–1.18 (t, 3H), 1.36–1.44 (m, 2H), 1.88–1.92 (m, 2H), 2.10–2.16 (m, 2H), 2.32 (s, 3H), 2.33–2.38 (q, 2H), 2.74–2.77 (m, 2H), 3.23–3.25 (m, 1H), 3.57–3.59 (d, 1H), 6.63 (d, <i>J</i> = 3.68 Hz, 1H), 6.92–6.93 (d, <i>J</i> = 1.72 Hz, 1H), 7.05–7.07 (d, <i>J</i> = 7.96 Hz, 1H), 7.13–7.54 (m, 5H), 8.02–8.04 (d, <i>J</i> = 8.28 Hz, 1H). HPLC purity: 98%.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-1<i>H</i>-indole (<b>12c</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3244, 2934, 2800, 1599, 1352, 1167, 1133. ESI mass: <i>m</i>/<i>e</i> 370 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.36–1.45 (m, 2H), 1.89–1.96 (m, 2H), 2.04–2.30 (m, 2H), 2.30 (s, 3H), 2.76–2.79 (m, 2H), 3.17–3.19 (m, 1H), 3.77–3.79 (d, 1H), 6.64–6.65 (m, 2H), 6.95–6.96 (t, 1H), 7.12–7.30 (m, 4H), 7.52–7.54 (m, 2H), 7.99–8.01 (d, <i>J</i> = 8.28 Hz, 1H). HPLC purity: 97%.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-fluorobenzenesulfonyl]-1<i>H</i>-indole (<b>12d</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3404, 2939, 1522, 1375, 1130. ESI mass: <i>m</i>/<i>e</i> 388 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.40–1.47 (m, 2H), 1.85–1.90 (m, 2H), 2.10–2.15 (m, 2H), 2.32 (s, 3H), 2.77–2.79 (m, 2H), 3.13–3.22 (m, 1H), 3.92–3.95 (m, 1H), 6.65–6.66 (m, 1H), 6.92–6.94 (d, <i>J</i> = 8.4 Hz, 1H), 6.95–6.97 (d, <i>J</i> = 8.44 Hz, 1H), 7.00–7.30 (m, 4H), 7.50–7.52 (m, 1H), 7.99 (m, 1H). HPLC purity: 97%.</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-chloro-1<i>H</i>-indole (<b>12e</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3423, 2937, 1520, 1268, 1135. MR (°C): 147–149. ESI mass: <i>m</i>/<i>e</i> 434 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.40–1.49 (m, 2H), 1.91–1.95 (m, 2H), 2.14–2.19 (m, 2H), 2.32 (s, 3H), 2.78–2.81 (m, 2H), 3.17–3.21 (m, 1H), 3.83 (s, 3H), 4.25–4.27 (d, 1H), 6.58–6.59 (d, <i>J</i> = 3.56 Hz, 1H), 6.66–6.71 (d, <i>J</i> = 8.52 Hz, 1H), 6.90–6.90 (d, <i>J</i> = 2.28 Hz, 1H), 7.17–7.2 (m, 2H), 7.41–7.43 (d, <i>J</i> = 8.36 Hz, 1H), 7.51–7.52 (d, <i>J</i> = 3.64 Hz, 1H), 8.05–8.06 (d, <i>J</i> = 1.56 Hz, 1H). HPLC purity: 98%.</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-ethylbenzenesulfonyl]-6-chloro-1<i>H</i>-indole (<b>12f</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3424, 2935, 1598, 1355, 1268, 1165, 1136. MR (°C): 143–147. ESI mass: <i>m</i>/<i>e</i> 432 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.16–1.20 (t, 3H), 1.43–1.45 (m, 2H), 1.94–2.01 (m, 2H), 2.16–2.21 (m, 2H), 2.32 (s, 3H), 2.35–2.40 (q, 2H), 2.77–2.80 (d, 2H), 3.27–3.29 (m, 1H), 3.62–3.64 (m, 1H), 6.59–6.60 (d, <i>J</i> = 3.56 Hz, 1H), 6.97–6.98 (d, <i>J</i> = 1.49 Hz, 1H), 7.07–7.14 (m, 2H), 7.18–7.20 (dd, <i>J</i> = 8.36, 1.77 Hz, 1H), 7.42–7.44 (d, <i>J</i> = 8.38 Hz, 1H), 7.52–7.53 (d, <i>J</i> = 3.60 Hz, 1H), 8.06 (bs, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-fluoro-1<i>H</i>-indole Hydrochloride (<b>12g</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its hydrochloride salt (<b>12g</b>) by treating with IPA·HCl. IR (cm<sup>–1</sup>): 3408, 2944, 2669, 1611, 1521, 1166. ESI mass: <i>m</i>/<i>e</i> 418 (M + H)<sup>+</sup>. MR (°C): 150–152. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.69–1.75 (m, 2H), 1.83–1.836 (m, 2H), 2.72 (s, 3H), 3.10–3.15 (m, 2H), 3.38–3.41 (m, 2H), 3.60 (m, 1H), 3.78 (s, 3H), 3.82 (bs, 1H), 6.78–6.79 (m, 1H), 6.91–7.23 (m, 4H), 7.59–7.62 (m, 1H), 7.76–7.78 (m, 2H), 10.60 (s, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-6-chloro-1<i>H</i>-indole Hydrochloride (<b>12h</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its hydrochloride salt (<b>12h</b>) by treating with IPA·HCl. IR (cm<sup>–1</sup>): 3403, 2939, 2797, 1601, 1374, 1174, 1139. ESI mass: <i>m</i>/<i>e</i> 404 (M + H)<sup>+</sup>. MR (°C): 126–128. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.43–1.48 (m, 2H), 1.92–1.97 (m, 2H), 2.10–2.16 (m, 2H), 2.31 (s, 3H), 2.78–2.81 (m, 2H), 3.19–3.26 (m, 1H), 3.81–3.83 (d, 1H), 6.60–6.61 (d, <i>J</i> = 3.99 Hz, 1H), 6.66–6.69 (m, 1H), 6.97–6.98 (m, 1H), 7.09–7.11 (m, 1H), 7.16–7.18 (d, <i>J</i> = 7.97 Hz, 1H), 7.19–7.21 (m, 1H), 7.42–7.45 (d, <i>J</i> = 8.37 Hz, 1H), 7.51–7.52 (d, <i>J</i> = 3.73 Hz, 1H), 8.03 (bs, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-bromo-1<i>H</i>-indole (<b>12i</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3404, 2931, 2783, 1440, 1354, 1259, 1145. MR (°C): 115–116. ESI mass: <i>m</i>/<i>e</i> 478, 480 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.37–1.46 (m, 2H), 1.85–1.88 (m, 2H), 2.08–2.16 (m, 2H), 2.32 (s, 3H), 2.78–2.81 (m, 2H), 3.11–3.18 (m, 1H), 3.83 (s, 3H), 4.23–4.25 (d, 1H), 6.55–6.56 (d, <i>J</i> = 3.64 Hz, 1H), 6.67–6.69 (d, <i>J</i> = 8.44 Hz, 1H), 6.79–6.80 (d, <i>J</i> = 2.24 Hz, 1H), 7.16–7.19 (dd, <i>J</i> = 8.44, 2.28 Hz, 1H), 7.37–7.39 (dd, <i>J</i> = 8.80, 1.88 Hz, 1H), 7.52–7.53 (d, <i>J</i> = 3.64 Hz, 1H), 7.65 (d, <i>J</i> = 1.84 Hz, 1H), 7.89–7.91 (d, <i>J</i> = 8.80 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-5-bromo-1<i>H</i>-indole (<b>12j</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3406, 1601, 1368, 1439, 1368, 1170, 1129. ESI mass: <i>m</i>/<i>e</i> 448, 450 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.42–1.47 (m, 2H), 1.89–1.93 (m, 2H), 2.08–2.17 (m, 2H), 2.32 (s, 3H), 2.79–2.82 (m, 2H), 3.17–3.19 (m, 1H), 3.79–3.81 (d, 1H), 6.58–6.59 (d, <i>J</i> = 3.64 Hz, 1H), 6.66–6.68 (m, 1H), 6.89–6.90 (m, 1H), 7.09–7.18 (m, 2H), 7.38–7.41 (dd, <i>J</i> = 7.92, 1.8 Hz, 1H), 7.52–7.53 (d, <i>J</i> = 3.68 Hz, 1H), 7.66–7.67 (d, <i>J</i> = 1.88 Hz, 1H), 7.87–7.89 (d, <i>J</i> = 8.80 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-fluorobenzenesulfonyl]-5-bromo-1<i>H</i>-indole (<b>12k</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3396, 2931, 2789, 1616, 1521, 1367, 1165, 1118. ESI mass: <i>m</i>/<i>e</i> 466, 468 (M + H)<sup>+</sup>. MR (°C): 85–87. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.39–1.48 (m, 2H), 1.85–1.88 (m, 2H), 2.09–2.17 (m, 2H), 2.33 (s, 3H), 2.78–2.81 (m, 2H), 3.16–3.17 (m, 1H), 3.96–3.97 (d, 1H), 6.59–6.60 (d, <i>J</i> = 3.56 Hz, 1H), 6.94–6.97 (m, 1H), 6.98–6.99 (d, <i>J</i> = 3.67 Hz, 1H), 7.07–7.11 (m, 1H), 7.39–7.42 (dd, <i>J</i> = 8.8, 1.84 Hz, 1H), 7.50–7.52 (d, <i>J</i> = 3.64 Hz, 1H), 7.67 (d, <i>J</i> = 1.80 Hz, 1H), 7.88–7.90 (d, <i>J</i> = 8.80 Hz, 1H). HPLC purity: 99.8%.</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methylbenzenesulfonyl]-5-fluoro-1<i>H</i>-indole (<b>12l</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3422, 2940, 1459, 1367, 1170, 1138. MR (°C): 129–131. ESI mass: <i>m</i>/<i>e</i> 402 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.39–1.46 (m, 2H), 1.88–1.91 (m, 2H), 2.05 (s, 3H), 2.11–2.16 (m, 2H), 2.33 (s, 3H), 2.78–2.80 (m, 2H), 3.17–3.28 (m, 1H), 3.51–3.52 (m, 1H), 6.58–6.59 (d, <i>J</i> = 3.68 Hz, 1H), 6.83–6.87 (m, 1H), 6.98–7.10 (m, 3H), 7.15–7.18 (dd, <i>J</i> = 8.77, 2.5 Hz, 1H), 7.56–7.56 (d, <i>J</i> = 3.61 Hz, 1H), 7.94–7.98 (dd, <i>J</i> = 9.06, 4.65 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-ethylbenzenesulfonyl]-5-fluoro-1<i>H</i>-indole (<b>12m</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3428, 2933, 1359, 1271, 1165, 1133. ESI mass: <i>m</i>/<i>e</i> 416 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.18–1.21 (t, 3H), 1.43–1.46 (m, 2H), 1.98–2.01 (m, 2H), 2.18–2.24 (m, 2H), 2.35 (s, 3H), 2.38–2.42 (q, 2H), 2.75–2.78 (d, 2H), 3.30 (m, 1H), 3.61–3.63 (m, 1H), 6.60–6.98 (m, 2H), 7.11–7.15 (m, 2H), 7.18–7.19 (m, 1H), 7.49–7.51 (d, 1H), 7.59–7.60 (d, <i>J</i> = 3.64 Hz, 1H), 8.1 (bs, 1H). HPLC purity: 95%.</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-fluoro-1<i>H</i>-indole (<b>12n</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3424, 2939, 1519, 1367, 1160, 1139. ESI mass: <i>m</i>/<i>e</i> 418 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.38–1.48 (m, 2H), 1.86–1.90 (m, 2H), 2.11–2.16 (m, 2H), 2.33 (s, 3H), 2.79–2.82 (m, 2H), 3.16–3.18 (m, 1H), 3.82 (s, 3H), 4.23–4.25 (d, 1H), 6.58 (d, <i>J</i> = 3.60 Hz, 1H), 6.67–6.69 (d, <i>J</i> = 8.48 Hz, 1H), 6.82 (d, <i>J</i> = 2.28 Hz, 1H), 7.01–7.02 (d, <i>J</i> = 2.52 Hz, 1H), 7.15–7.19 (m, 2H), 7.55–7.56 (d, <i>J</i> = 3.6 Hz, 1H), 7.94–7.97 (m, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-ethylbenzenesulfonyl]-4-chloro-1<i>H</i>-indole (<b>12o</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3427, 3124, 2927, 1587, 1512, 1359, 1274, 1166, 1139. ESI mass: <i>m</i>/<i>e</i> 432, 434 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.16–1.19 (t, 3H), 1.41–1.46 (m, 2H), 1.89–1.93 (m, 2H), 2.12–2.17 (m, 2H), 2.33 (s, 3H), 2.34–2.39 (q, 2H), 2.77–2.79 (m, 2H), 3.24–3.25 (m, 1H), 3.61–3.63 (d, 1H), 6.75–6.76 (d, <i>J</i> = 3.72 Hz, 1H), 6.88–6.89 (d, <i>J</i> = 1.76 Hz, 1H), 7.07–7.09 (d, <i>J</i> = 7.96 Hz, 1H), 7.13–7.23 (m, 3H), 7.58–7.59 (d, <i>J</i> = 3.68 Hz, 1H), 7.92–7.94 (m, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-1<i>H</i>-indole (<b>12p</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3418, 2940, 1519, 1166, 1129. ESI mass: <i>m</i>/<i>e</i> 434, 436 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.38–1.44 (2H, m), 1.85–1.89 (m, 2H), 2.09–2.15 (m, 2H), 2.33 (s, 3H), 2.79–2.81 (m, 2H), 3.09–3.20 (m, 1H), 3.82 (s, 3H), 4.23–4.25 (m, 1H), 6.55–6.56 (m, 1H), 6.67–6.69 (d, <i>J</i> = 8.48 Hz, 1H), 6.80–6.81 (d, <i>J</i> = 2.28 Hz, 1H), 7.16–7.19 (dd, <i>J</i> = 8.48, 2.4, 2.32 Hz, 1H), 7.23–7.26 (m, 1H), 7.48–7.49 (d, <i>J</i> = 2.04 Hz, 1H), 7.54 (d, <i>J</i> = 3.6 Hz, 1H), 7.94–7.96 (d, <i>J</i> = 8.92 Hz, 1H). HPLC purity: 98%.</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-methoxy-1<i>H</i>-indole (<b>12q</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3400, 2941, 1521, 1169, 1148. MR (°C): 118–120. ESI mass: <i>m</i>/<i>e</i> 430 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.37–1.46 (m, 2H), 1.86–1.90 (m, 2H), 2.10–2.16 (m, 2H), 2.33 (s, 3H), 2.78–2.81 (m, 2H), 3.15–3.17 (m, 1H), 3.80–3.81 (d, 6H), 4.20–4.22 (d, <i>J</i> = 7.91 Hz, 1H), 6.54–6.55 (d, <i>J</i> = 3.62 Hz, 1H), 6.65–6.67 (d, <i>J</i> = 8.47 Hz, 1H), 6.82–6.83 (d, <i>J</i> = 2.22 Hz, 1H), 6.88–6.91 (dd, <i>J</i> = 9.02, 2.48 Hz, 1H), 6.95–6.96 (d, <i>J</i> = 2.25 Hz, 1H), 7.15–7.18 (dd, <i>J</i> = 8.42, 2.25 Hz, 1H), 7.47–7.48 (d, <i>J</i> = 3.59 Hz, 1H), 7.90–7.92 (d, <i>J</i> = 8.96 Hz, 1H). HPLC purity: 98 <b>%.</b></div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methylbenzenesulfonyl]-5-methoxy-1<i>H</i>-indole (<b>12r</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3412, 1928, 1467, 1364, 1147. ESI mass: <i>m</i>/<i>e</i> 414 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.42–1.48 (m, 2H), 1.88–1.92 (m, 2H), 2.04 (s, 3H), 2.10–2.17 (m, 2H), 2.35 (s, 3H), 2.81–2.84 (m, 2H), 3.19–3.28 (m, 2H), 3.47–3.52 (m, 1H), 3.81 (s, 3H), 6.55–6.56 (d, <i>J</i> = 3.56 Hz, 1H), 6.86 (d, <i>J</i> = 1.52 Hz, 1H), 6.88–6.91 (dd, <i>J</i> = 9.02, 2.52 Hz, 1H), 6.96 (d, <i>J</i> = 2.48 Hz, 1H), 7.03–7.05 (d, <i>J</i> = 7.88 Hz, 1H), 7.06–7.09 (dd, <i>J</i> = 7.82, 1.72 Hz, 1H), 7.47–7.48 (d, <i>J</i> = 3.6 Hz, 1H), 7.90–7.92 (d, <i>J</i> = 8.96 Hz, 1H). HPLC purity: 98%.</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-fluorobenzenesulfonyl]-5-methoxy-1<i>H</i>-indole (<b>12s</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3400, 3138, 2943, 1610, 1525, 169, 1224, 1145. MR (°C): 157–160. ESI mass: <i>m</i>/<i>e</i> 418 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.44–1.49 (m, 2H), 1.87–1.90 (m, 2H), 2.12–2.17 (m, 2H), 2.34 (s, 3H), 2.81–2.83 (m, 2H), 3.18 (m, 1H), 3.81 (s, 3H), 3.93–3.94 (m, 1H), 6.58 (d, <i>J</i> = 3.56 Hz, 1H), 6.90–6.99 (m, 4H), 7.07–7.09 (m, 1H), 7.45–7.46 (d, 1H), 7.88–7.90 (d, 1H). HPLC purity: 98.5%.</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-5-methoxy-1<i>H</i>-indole (<b>12t</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3410, 3255, 1600, 1366, 1225, 1148. ESI mass: <i>m</i>/<i>e</i> 400 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.38–1.48 (m, 2H), 1.90–2.00 (m, 2H), 2.10–2.15 (m, 2H), 2.32 (s, 3H), 2.80–2.82 (m, 2H), 3.18–3.20 (m, 1H), 3.76–3.78 (d, 1H), 3.81 (s, 3H), 6.57–6.58 (d, <i>J</i> = 3.56 Hz, 1H), 6.64–6.66 (m, 1H), 6.90–6.93 (m, 2H), 6.97 (d, <i>J</i> = 2.26 Hz, 1H), 7.09–7.14 (m, 2H), 7.48–7.49 (d, <i>J</i> = 3.59 Hz, 1H), 7.88–7.90 (d, <i>J</i> = 9.07 Hz, 1H). HPLC purity: 95%.</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-methoxy-1<i>H</i>-indole Phosphate (<b>12u</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its phosphate salt (<b>12u</b>) by treating with <i>o</i>-phosphoric acid. IR (cm<sup>–1</sup>): 3391, 2951, 1614, 1522, 1285, 1215, 1166, 1115, 1013. ESI mass: <i>m</i>/<i>e</i> 430 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.51–1.56 (m, 2H), 1.74–1.77 (m, 2H), 2.52–2.54 (m, 2H), 3.02–3.07 (m, 2H), 3.15 (s, 3H), 3.37 (m, 1H), 3.78 (s, 3H), 3.80 (s, 3H), 5.18–5.20 (d, 1H), 6.68–6.69 (d, <i>J</i> = 3.67 Hz, 1H), 6.83–6.92 (m, 3H), 7.16–7.19 (dd, <i>J</i> = 8.48, 2.25 Hz, 1H), 7.42–7.46 (m, 2H), 7.59–7.60 (d, <i>J</i> = 3.70 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methylbenzenesulfonyl]-6-methoxy-1<i>H</i>-indole Diphosphate (<b>12v</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its phosphate salt (<b>12v</b>) by treating with <i>o</i>-phosphoric acid. IR (cm<sup>–1</sup>): 3416, 2946, 1362, 1214, 1168. MR (°C): 182–186. ESI mass: <i>m</i>/<i>e</i> 414 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.60 (bs, 2H), 1.85–1.89 (m, 2H), 2.05 (s, 3H), 2.49–2.52 (m, 2H), 2.65 (m, 2H), 3.10 (m, 3H), 3.80 (s, 3H), 5.10 (bs, 1H), 6.69–6.70 (d, <i>J</i> = 3.54 Hz, 1H), 6.82 (s, 1H), 6.87–6.90 (dd, <i>J</i> = 8.60, 2.18 Hz, 1H), 7.04–7.06 (dd, <i>J</i> = 7.78, 1.46 Hz, 1H), 7.12–7.14 (d, <i>J</i> = 7.83 Hz, 1H), 7.40–7.41 (d, <i>J</i> = 1.9 Hz, 1H), 7.45–7.47 (d, <i>J</i> = 8.62 Hz, 1H), 7.58–7.59 (d, <i>J</i> = 3.59 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-chlorobenzenesulfonyl]-6-methoxy-1<i>H</i>-indole Hydrochloride (<b>12w</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its hydrochloride salt (<b>12w</b>) by treating with IPA·HCl. IR (cm<sup>–1</sup>): 3421, 3092, 2944, 1614, 1370, 1166, 1118. ESI mass: <i>m</i>/<i>e</i> 434 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.70–1.76 (m, 2H), 1.82–1.85 (m, 2H), 2.76 (s, 3H), 3.09–3.11 (m, 2H), 3.22 (m, 2H), 3.65 (m, 1H), 3.81 (s, 3H), 5.80–5.82 (d, 1H), 6.74–6.75 (d, <i>J</i> = 3.32 Hz, 1H), 6.90–6.92 (m, 1H), 7.09–7.12 (m, 2H), 7.41–7.49 (m, 3H), 7.63–7.64 (d, <i>J</i> = 3.42 Hz, 1H), 10.03 (bs, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-6-methoxy-1<i>H</i>-indole Phosphate (<b>12x</b>)</h4><div class="NLM_p last">The free base of title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. This was converted to its phosphate salt (<b>12x</b>) by treating with <i>o</i>-phosphoric acid. IR (cm<sup>–1</sup>): 3379, 2719, 1601, 1213, 1174, 1116. MR (°C): 145–148. ESI mass: <i>m</i>/<i>e</i> 400 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.44–1.76 (m, 2H), 1.83–1.86 (m, 2H), 2.54–2.57 (m, 2H), 3.02 (s, 3H), 3.30 (m, 2H), 3.80 (s, 3H), 4.07 (m, 1H), 6.72–6.73 (d, <i>J</i> = 3.76 Hz, 1H), 6.79–6.81 (m, 1H), 6.88–6.90 (dd, <i>J</i> = 8.65, 2.23 Hz, 1H), 7.00–7.02 (m, 2H), 7.20–7.24 (m, 1H), 7.38 (bs, 1H), 7.47–7.49 (d, <i>J</i> = 8.62 Hz, 1H), 7.56–7.57 (d, <i>J</i> = 3.66 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-isopropoxy-1<i>H</i>-indole (<b>12y</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3403, 2937, 1519, 1454, 1147. ESI mass: <i>m</i>/<i>e</i> 458 (M + H)<sup>+</sup>. MR (°C): 116–118. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.31–1.32 (d, <i>J</i> = 6.08 Hz, 6H), 1.39–1.44 (m, 2H), 1.86–1.89 (m, 2H), 2.08–2.14 (m, 2H), 2.31 (s, 3H), 2.76–2.79 (m, 2H), 3.15–3.17 (m, 1H), 3.81 (s, 3H), 4.20–4.22 (d, <i>J</i> = 7.84 Hz, 1H), 4.47–4.53 (q, 1H), 6.52–6.53 (d, <i>J</i> = 3.6 Hz, 1H), 6.65–6.67 (d, <i>J</i> = 8.52 Hz, 1H), 6.83–6.84 (d, <i>J</i> = 2.2 Hz, 1H), 6.86–6.89 (dd, <i>J</i> = 8.98, 2.44 Hz, 1H), 6.95–6.96 (d, <i>J</i> = 2.4 Hz, 1H), 7.16–7.18 (dd, <i>J</i> = 8.40, 2.24 Hz), 7.46–7.47 (d, <i>J</i> = 3.6 Hz, 1H), 7.88–7.90 (d, <i>J</i> = 9.0 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-fluorobenzenesulfonyl]-3-methyl-1<i>H</i>-indole (<b>12z</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3398, 2939, 1365, 1168, 1128. ESI mass: <i>m</i>/<i>e</i> 402 (M + H)<sup>+</sup>. MR (°C): 136–138. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.38–1.47 (m, 2H), 1.85–1.88 (m, 2H), 2.10–2.15 (m, 2H), 2.23 (s, 3H), 2.33 (s, 3H), 2.77–2.80 (m, 2H), 3.17–3.19 (m, 1H), 3.91–3.92 (d, 1H), 6.91–6.95 (m, 1H), 6.98–7.01 (dd, <i>J</i> = 8.46, 2.20 Hz, 1H), 7.07–7.11 (m, 1H), 7.23–7.32 (m, 3H), 7.45–7.47 (d, <i>J</i> = 7.57 Hz, 1H), 7.98–8.01 (d, <i>J</i> = 8.16 Hz, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-fluoro-3-methyl-1<i>H</i>-indole (<b>12aa</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3417, 2931, 2773, 1593, 1363, 1159, 1103. ESI mass: <i>m</i>/<i>e</i> 432 (M + H)<sup>+</sup>. MR (°C): 172–174. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.36–1.45 (m, 2H), 1.85–1.88 (m, 2H), 2.08–2.13 (m, 2H), 2.18 (s, 3H), 2.32 (s, 3H), 2.77–2.80 (m, 2H), 3.14–3.16 (m, 1H), 3.81 (s, 3H), 4.20–4.22 (d, 1H), 6.65–6.67 (d, <i>J</i> = 8.44 Hz, 1H), 6.80 (d, <i>J</i> = 2.24 Hz, 1H), 7.00–7.09 (m, 2H), 7.13–7.16 (m, 1H), 7.30 (m, 1H), 7.93–7.96 (m, 1H). HPLC purity: 99%.</div></div><div id="sec5_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-chloro-3-methyl-1<i>H</i>-indole (<b>12ac</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. IR (cm<sup>–1</sup>): 3400, 2937, 2779, 1518, 1363, 1169, 1136. MR (°C): 179–181. ESI mass: <i>m</i>/<i>e</i> 448 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.40–1.47 (m, 2H), 1.62 (m, 2H), 1.90–1.93 (m, 2H), 2.20 (s, 3H), 2.32 (s, 3H), 2.78–2.81 (m, 2H), 3.19 (m, 1H), 3.83 (s, 3H), 4.23–4.25 (d, 1H), 6.68–6.70 (d, <i>J</i> = 8.38 Hz, 1H), 6.88 (bs, 1H), 7.15–7.35 (m, 4H), 8.04 (bs, 1H). HPLC purity: 98%.</div></div><div id="sec5_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-methoxy-3-methyl-1<i>H</i>-indole (<b>12ad</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>12ab</b>. ESI mass: <i>m</i>/<i>e</i> 444 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.71–1.83 (m, 2H), 1.99–2.02 (m, 2H), 2.18 (s, 3H), 2.87 (s, 3H), 3.08–3.17 (m, 2H), 3.44–3.51 (m, 3H), 3.84 (s, 3H), 3.87 (s, 3H), 6.85–6.90 (m, 3H), 7.20 (m, 2H), 7.34–7.36 (d, <i>J</i> = 8.62 Hz, 1H), 7.53 (s, 1H). HPLC purity: 99.54%.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> General Procedures (Compounds <b>13</b>, <b>14</b>, <b>15</b>, <b>16</b>, <b>17</b>, <b>18a</b>–<b>18s</b>, and <b>19a</b>–<b>19e</b>)</h3><div class="NLM_p">2-(Substituted/unsubstituted) anilines (1 mmol) were reacted with trifluoroacetic anhydride (1.2 mmol) in the presence of pyridine (1.5 mmol) in dichloromethane at 0–5 °C. After completion of the reaction (TLC), the reaction mass was poured onto water and the product was extracted with ethyl acetate. The organic layer was washed with brine solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain <i>N</i>-(2-substituted/unsubstituted phenyl)-2,2,2-trifluoroacetamide. This was treated with chlorosulfonic acid (1.5 mmol) in dichloromethane at 0–5 °C. The mixture was stirred for 2 h. After completion of the reaction (TLC), the reaction mass was carefully poured onto ice–water and extracted with dichloromethane. The organic layer was dried over sodium sulfate and concentrated under reduced pressure to obtain 4-(substituted/unsubstituted)-3-(2,2,2-trifluoroacetamido) benzenesulfonyl chloride intermediates <b>14</b>. The substituted aromatic heterocycles <b>13</b> (1 mmol) were reacted with <b>14</b> (1.5 mmol) in the presence of sodium hydride (3 mmol) in DMF at 0–5 °C and stirred at room temperature for 12–24 h. After completion of the reaction (TLC), the reaction mass was poured onto water and extracted with dichloromethane. The organic layer was dried over sodium sulfate and concentrated under reduced pressure to obtain crude mass, which was purified by flash column chromatography using ethyl acetate–hexanes (8:2) as eluent to obtain intermediates <b>15.</b> These intermediates <b>15</b> were refluxed in ethanol–conc HCl mixture for 2–10 h. After completion of the reaction (TLC), the solvent was removed in vacuo. The oil was poured onto water, neutralized with 10% sodium hydroxide solution, and extracted with dichloromethane. The organic layer was separated, dried over sodium sulfate, and concentrated in vacuo to obtain intermediates <b>16</b>. These amine intermediates <b>16</b> (1 mmol) were treated with 1-methyl-4-piperidone (3 mmol) or 1-Boc-4-piperidone (3 mmol) in presence of sodium triacetoxyborohydride (3 mmol), acetic acid, and sodium sulfate (10 mmol) as discussed in the general procedure for Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> to obtain the targeted compounds <b>18</b> and Boc protected intermediates <b>17</b>, respectively. The deprotection of intermediates <b>17</b> (1 mmol) with isopropanolic HCl (20% w/v solution, 2.5 mL) gave targeted compounds <b>19</b> as their corresponding HCl salts.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-Chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>, Het = A)</h4><div class="NLM_p last">Phosphorus oxychloride (10 g, 65.8 mmol) was added to a stirred solution of 5-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (5 g, 32.9 mmol) in DMF (25 mL) at 0–5 °C. The stirred mixture was heated at 60 °C for 6 h, cooled to room temperature, and poured onto cold water (50 mL). The pH of the reaction mass was adjusted to ∼12 with cold aq NaOH solution and extracted the product with chloroform (3 × 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. The resultant residual mass was chromatographed (silica gel, 3:7 to 1:1 ethyl acetate–hexanes as eluent) to obtain 5-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxaldehyde as off-white solid, 2.07 g (35% yield). ESI mass: <i>m</i>/<i>e</i> 179 (M– H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.37–8.39 (m, 2H), 8.55 (s, 1H), 9.91 (s, 1H), 12.92 (bs, 1H). HPLC purity: 99.5%. Hydrazine hydrate (4.2 g, 83.3 mmol) was added to a stirred suspension of 5-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carboxaldehyde (5 g, 27.7 mmol) and KOH powder (4.7 g, 83.3 mmol) in ethylene glycol (50 mL) at room temperature. The mixture was heated at 180 °C for 5 h. After completion of the reaction (TLC), the reaction mass was cooled to room temperature and poured onto cold water (100 mL). The solids that separated were filtered, dissolved in ethyl acetate (100 mL), and separated the aqueous layer, and the organic layer was concentrated in vacuo to obtain the title compound <b>13</b>, Het = A as off-white solid (3.78 g, 82% yield). ESI mass: <i>m</i>/<i>e</i> 167 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 2.23 (s, 3H), 7.33 (s, 1H), 8.02–8.03 (d, <i>J</i> = 2.20 Hz, 1H), 8.16 (d, <i>J</i> = 2.24 Hz, 1H), 11.54 (bs, 1H).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-Methoxy-3-(2,2,2-trifluoroacetamido)benzenesulfonyl Chloride (<b>14</b>, R<sup>1</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p">Trifluoroacetic anhydride (12.6 g, 60 mmol) was added to a stirred solution of <i>o</i>-anisidine (6.15 g, 50 mmol) and pyridine (5.9 g, 75 mmol) in dichloromethane (60 mL) at 0–5 °C. Then the reaction mixture was warmed to room temperature and stirred for 2 h. After completion of the reaction (TLC), the reaction mass was poured onto water and the product was extracted with ethyl acetate (3 × 100 mL). Combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to obtain 9.2 g of <i>N</i>-(2-methoxy phenyl)-2,2,2-trifluoroacetamide (84% yield). ESI mass: <i>m</i>/<i>e</i> 218 (M – H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 3.92 (s, 3H), 6.92–6.94 (d, <i>J</i> = 8.19 Hz, 1H), 6.99–7.02 (m, 1H), 7.15–7.19 (m, 1H), 8.29–8.31 (d, <i>J</i> = 8.03 Hz, 1H), 8.58–8.61 (bs, 1H).</div><div class="NLM_p last">Chlorosulfonic acid (7.2 g, 61 mmol) was added to a solution of <i>N</i>-(2-methoxy phenyl)-2,2,2-trifluoroacetamide (9 g, 41 mmol) in dichloromethane (100 mL) at 0–5 °C. The reaction mass was warmed to room temperature, stirred for 2 h, and then carefully poured onto water (50 mL). The mass was extracted with ethyl acetate (3 × 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to obtain 11.4 g of (<b>14</b>, R<sup>1</sup> = OCH<sub>3</sub>) as solids (88% yield). ESI mass: <i>m</i>/<i>e</i> 316 (M – H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.09 (s, 3H), 7.10–7.12 (d, <i>J</i> = 8.81 Hz, 1H), 7.89–7.92 (m, 1H), 8.59 (bs, 1H), 9.05–9.06 (d, <i>J</i> = 2.22 Hz, 1H).</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-[3-(2,2,2-Trifluoroacetamido)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p last">A solution of 5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>, Het = A, 5 g, 30.1 mmol) in DMF (10 mL) was added to a stirred suspension of NaH (3.6 g, 90.3 mmol, 60% w/v oil suspension) in DMF (25 mL) below 10 °C under N<sub>2</sub> atmosphere. The mixture was further stirred for 30 min at 5–10 °C. A solution of 4-methoxy-3-(2,2,2-trifluoroacetamido)benzenesulfonyl chloride (<b>14</b>, R<sup>1</sup> = OCH<sub>3</sub>, 14.3 g, 45.1 mmol) in DMF (25 mL) was added to the above mass and stirred overnight. After completion of the reaction (TLC), the reaction mass was poured onto cold water (100 mL) and the product was extracted with chloroform (4 × 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. The resultant residual mass was chromatographed (silica gel, 2:8 to 1:1 ethyl acetate–hexanes as eluent) to obtain the title compound, as pale-yellow solid (10.5 g, 78% yield). ESI mass: <i>m</i>/<i>e</i> 448, 450 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.24 (s, 3H), 3.99 (s, 3H), 7.01–7.03 (d, <i>J</i> = 8.80 Hz, 1H), 7.55 (s, 1H), 7.76–7.77 (d, <i>J</i> = 2.09 Hz, 1H), 8.17–8.19 (dd, <i>J</i> = 8.77, 2.32 Hz, 1H), 8.36 (d, <i>J</i> = 2.27 Hz, 1H), 8.48 (bs, 1H), 8.97–8.98 (d, <i>J</i> = 2.29 Hz, 1H).</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(3-Amino-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p last">A solution of 1-[3-(2,2,2-trifluoroacetamido)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (10 g, 22.3 mmol) in a mixture of ethanol–water–conc hydrochloric acid (300 mL, 1:1:1) was refluxed for 6 h. After completion of the reaction (TLC), the mass was cooled and concentrated in vacuo. The residual mass was diluted with cold water (50 mL), neutralized with aq NaOH, and extracted the product with chloroform (3 × 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo. The resultant residual mass was chromatographed (silica gel, 1:1 to 1:0 ethyl acetate–hexanes as eluent) to obtain the title product as white solid (3.7 g, 48% yield). ESI mass: <i>m</i>/<i>e</i> 352, 354 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.59 (bs, 2H), 2.24 (s, 3H), 3.87 (s, 3H), 6.77–6.80 (d, <i>J</i> = 8.56 Hz, 1H), 7.40 (d, <i>J</i> = 2.28 Hz, 1H), 7.49 (s, 1H), 7.52–7.55 (dd, <i>J</i> = 8.54, 2.29 Hz, 1H), 7.75–7.76 (d, <i>J</i> = 2.25 Hz, 1H), 8.36–8.37 (d, <i>J</i> = 2.21 Hz, 1H). HPLC purity: 99.5%.</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-[3-(1-<i>tert</i>-Butyloxycarbonyl Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>)</h4><div class="NLM_p last">Sodium triacetoxyborohydride (1.8 g, 8.4 mmol) was added in portions to a stirred suspension of 1-(3-amino-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>, 1 g, 2.8 mmol), 1-boc-4-piperidone (1.7 g, 8.4 mmol), and sodium sulfate (3.4 g, 24 mmol) in glacial acetic acid (20 mL) at room temperature under N<sub>2</sub> atmosphere. The mass was stirred overnight at room temperature. After completion of the reaction (TLC), the mixture was poured onto cold water, neutralized with aq NaOH solution, and extracted with chloroform (3 × 50 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to obtain an oily residue. The mass was chromatographed (neutral silica gel, 20:80 ethyl acetate–hexanes) to afford the title product as an oily mass (0.6 g, 40% yield). ESI mass: <i>m</i>/<i>e</i> 535, 537 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.40–1.43 (m, 2H), 1.46 (s, 9H), 1.85–1.88 (m, 2H), 2.22 (s, 3H), 2.97–3.04 (m, 4H), 3.43–3.45 (m, 1H), 3.85 (s, 3H), 4.04–4.07 (bs, 1H), 6.78–6.80 (d, <i>J</i> = 8.6 Hz, 1H), 7.44–7.47 (m, 3H), 7.73–7.74 (d, <i>J</i> = 2.0 Hz, 1H), 8.32 (d, <i>J</i> = 2.07 Hz, 1H). HPLC purity: 98.9%.</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>18</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>)</h4><div class="NLM_p last">Sodium triacetoxyborohydride (21.2 g, 99.9 mmol) was added in portions to a stirred suspension of 1-(3-amino-4-methoxybenzenesulfonyl)-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (11.7 g, 33.3 mmol), 1-methyl-4-piperidone (11.3 g, 99.9 mmol), and sodium sulfate (47.3 g, 333.3 mmol) in glacial acetic acid (110 mL) at room temperature under N<sub>2</sub> atmosphere. The mass was stirred overnight at room temperature. After completion of the reaction (TLC), the mixture was poured onto cold water, neutralized with aq NaOH solution, and extracted with chloroform (3 × 150 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated in vacuo to obtain an oily residue. The mass was chromatographed (neutral silica gel, 80:20 ethyla cetate–hexanes, and then 5:95 methanol–ethyl acetate) to afford the title product as an oily mass (5.56 g, 37% yield). ESI mass: <i>m</i>/<i>e</i> 449, 451 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.34–1.40 (m, 2H), 1.68–1.71 (m, 2H), 1.99–2.05 (m, 2H), 2.18 (s, 3H), 2.19 (s, 3H), 2.69–2.71 (m, 2H), 3.08–3.16 (m, 1H), 3.80 (s, 3H), 4.99–5.01 (d, <i>J</i> = 8.13 Hz, 1H), 6.91–6.93 (d, <i>J</i> = 8.52 Hz, 1H), 7.06 (d, <i>J</i> = 2.20 Hz, 1H), 7.21–7.24 (dd, <i>J</i> = 8.42, 2.22 Hz, 1H), 7.72 (s, 1H), 8.17–8.18 (d, <i>J</i> = 2.30 Hz, 1H), 8.35–8.36 (d, <i>J</i> = 2.30 Hz, 1H). HPLC purity: 98.8%.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedure for the Preparation of <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate Salt</h3><div class="NLM_p">Compounds <b>18</b> (1 mmol) were treated with <span class="smallcaps smallerCapital">l</span>-(+)-tartaric acid (1 mmol) in methanol under N<sub>2</sub> atmosphere for 2 h and then concentrated under reduced pressure to obtain respective <span class="smallcaps smallerCapital">l</span>-(+)-tartarate salts.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18c</b>)</h4><div class="NLM_p"><span class="smallcaps smallerCapital">l</span>(+)-Tartaric acid (1.84 g, 12.3 mmol) was added to a stirred solution of 1-[3-(1-methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (18, Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3,</sub> 5.5 g, 12.3 mmol) in methanol (50 mL) under N<sub>2</sub> atmosphere. The resulting solution was stirred at room temperature for 2 h and concentrated in vacuo to obtain 7.3 g (100% yield) of the title compound as off-white solid. ESI mass: <i>m</i>/<i>e</i> 449, 451 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.59–1.65 (m, 2H), 1.81–1.84 (m, 2H), 2.19 (s, 3H), 2.57 (s, 3H), 2.76–2.82 (m, 2H), 3.16–3.18 (m, 2H), 3.39–3.42 (m, 1H), 3.80 (s, 3H), 4.07 (s, 2H), 5.23–5.25 (d, <i>J</i> = 8.00 Hz, 1H), 6.91–6.94 (d, <i>J</i> = 8.54 Hz, 1H), 7.11 (d, <i>J</i> = 1.89 Hz, 1H), 7.22–7.24 (dd, <i>J</i> = 8.41, 1.96 Hz, 1H), 7.71 (s, 1H), 8.17 (d, <i>J</i> = 2.19 Hz, 1H), 8.37 (d, <i>J</i> = 2.16 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.54, 29.43, 43.91, 47.22, 53.07, 56.23, 72.11, 106.75, 109.81, 114.89, 116.33, 125.0, 126.0, 126.39, 128.37, 129.69, 137.28, 142.79, 145.54, 151.17, 174.31. HPLC purity: 99.1%.</div><div class="NLM_p last">Compounds <b>18a</b>–<b>18b</b> and <b>18d</b>–<b>18s</b> were prepared analogously.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-[3-(1-Methylpiperidin-4-ylamino)benzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18a</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 419, 421 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 1.68–1.77 (m, 2H), 2.14–2.17 (m, 2H), 2.25 (s, 3H), 2.87 (s, 3H), 3.14–3.17 (m, 2H), 3.35–3.48 (m, 2H), 3.59–3.62 (m, 1H), 4.43 (s, 2H), 6.85–6.87 (d, <i>J</i> = 7.14 Hz, 1H), 7.19–7.25 (m, 2H), 7.31 (s, 1H), 7.60 (s, 1H), 8.00–8.01 (s, <i>J</i> = 2.13 Hz, 1H), 8.28 (s, <i>J</i> = 2.10 Hz, 1H). HPLC purity: 97.0%.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methylbenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18b</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 433, 435 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 1.79–1.87 (m, 2H), 2.13 (s, 3H), 2.19–2.29 (m, 2H), 2.24 (s, 3H), 2.91 (s, 3H), 3.21–3.24 (m, 2H), 3.48–3.53 (m, 2H), 3.67–3.71 (m, 1H), 4.43 (s, 2H), 7.12–7.19 (m, 2H), 7.32 (s, 1H), 7.60 (s, 1H), 8.00–8.01 (d, <i>J</i> = 2.15 Hz, 1H), 8.28 (s, <i>J</i> = 2.11 Hz, 1H).</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine (<b>18d</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). ESI mass: <i>m</i>/<i>e</i> 449, 451(M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.84–1.88 (m, 4H), 2.21 (s, 3H), 2.39–2.52 (m, 5H), 3.08–3.10 (m, 2H), 3.22–3.26 (m, 1H), 3.85 (s, 3H), 4.30–4.32 (d, <i>J</i> = 8.04 Hz, 1H), 6.70–6.72 (d, <i>J</i> = 8.48 Hz, 1H), 6.84–6.85 (d, <i>J</i> = 2.14 Hz, 1H), 7.19–7.22 (dd, <i>J</i> = 8.37, 2.13 Hz, 1H), 7.40–7.41 (m, 2H), 9.08 (s, 1H). HPLC purity: 96.8%.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18e</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 449, 451 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.53–1.55 (m, 2H), 1.75–1.77 (m, 2H), 1.98 (s, 3H), 2.56 (s, 3H), 2.72–2.75 (m, 2H), 3.11–3.15 (m, 2H), 3.34–3.58 (m, 1H), 3.79 (s, 3H), 4.11 (s, 2H), 5.29–5.32 (d, <i>J</i> = 8.16 Hz, 1H), 6.85 (s, 1H), 6.90–6.93 (d, <i>J</i> = 8.47 Hz, 1H), 7.17–7.19 (m, 1H), 7.38–7.41 (d, <i>J</i> = 8.62 Hz, 1H), 8.00 (s, 1H), 8.33–8.36 (d, <i>J</i> = 8.63 Hz, 1H). HPLC purity: 96.3%.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18f</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 435, 437 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 1.71–1.76 (m, 2H), 2.16–2.21 (m, 2H), 2.91 (s, 3H), 3.13–3.24 (m, 2H), 3.48–3.52 (m, 2H), 3.63–3.68 (m, 1H), 3.88 (s, 3H), 4.45 (s, 2H), 6.68–6.69 (d, <i>J</i> = 3.79 Hz, 1H), 6.92–6.94 (d, <i>J</i> = 8.23 Hz, 1H), 7.36–7.38 (m, 2H), 7.84–7.85 (d, <i>J</i> = 3.72 Hz, 1H), 8.04 (s, 1H), 8.29 (s, 1H). HPLC purity: 97.4%.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-methoxy-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>18g</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). ESI mass: <i>m</i>/<i>e</i> 431 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.66–1.68 (m, 2H), 2.06–2.12 (m, 2H), 2.49–2.55 (m, 5H), 3.08–3.12 (m, 2H), 3.47–3.49 (m, 1H), 3.85 (s, 6H), 4.28–4.30 (d, <i>J</i> = 6.96 Hz, 1H), 6.49–6.50 (d, <i>J</i> = 3.82 Hz, 1H), 6.72–6.74 (d, <i>J</i> = 8.29 Hz, 1H), 7.31–7.31 (d, <i>J</i> = 2.35 Hz, 1H), 7.37–7.39 (d, <i>J</i> = 7.79 Hz, 2H), 7.65–7.66 (d, <i>J</i> = 3.80 Hz, 1H), 8.11 (d, <i>J</i> = 1.99 Hz, 1H). HPLC purity: 99.8%.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-methoxy-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18h</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 445 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 1.69–1.76 (m, 2H), 2.12–2.15 (m, 2H), 2.23 (s, 3H), 2.84 (s, 3H), 3.13–3.27 (m, 2H), 3.48–3.52 (m, 2H), 3.59–3.63 (m, 1H), 3.85 (s, 3H), 3.88 (s, 3H), 4.46 (s, 2H), 6.86–6.88 (d, <i>J</i> = 8.94 Hz, 1H), 7.26–7.27 (m, 2H), 7.47–7.49 (m, 2H), 8.01–8.02 (d, <i>J</i> = 2.32 Hz, 1H). HPLC purity: 95.8%.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-indazole <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18i</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 449, 451 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.46–1.49 (m, 2H), 1.72–1.89 (m, 2H), 2.07 (s, 3H), 2.45 (s, 3H), 2.88–3.25 (m, 4H), 3.31–3.33 (m, 1H), 3.79 (s, 3H), 4.19 (s, 2H), 5.20–5.22 (d, <i>J</i> = 7.19 Hz, 1H), 6.74–6.74 (d, <i>J</i> = 1.66 Hz, 1H), 6.89–6.91 (d, <i>J</i> = 8.50 Hz, 1H), 7.10–7.13 (dd, <i>J</i> = 8.42, 2.1 Hz, 1H), 7.63–7.66 (dd, <i>J</i> = 8.89, 1.90 Hz, 1H), 7.95 (d, <i>J</i> = 1.79 Hz, 1H), 8.07–8.09 (d, <i>J</i> = 8.89 Hz, 1H). HPLC purity: 98.5%.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-fluorobenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-indazole <span class="smallcaps smallerCapital">l</span>-(+)-Tartarate (<b>18j</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18c</b>. ESI mass: <i>m</i>/<i>e</i> 437, 439 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.49–1.57 (m, 2H), 1.71–1.74 (m, 2H), 1.88 (s, 3H), 2.46 (s, 3H), 2.57–2.61 (m, 2H), 3.07–3.09 (m, 2H), 3.33–3.35 (m, 1H), 4.01–4.09 (s, 2H), 6.01–6.03 (d, <i>J</i> = 7.58 Hz, 1H), 6.98–7.00 (d, <i>J</i> = 7.69 Hz, 1H), 7.05–7.07 (m, 1H), 7.17–7.22 (m, 1H), 7.65–7.68 (dd, <i>J</i> = 8.89, 1.74 Hz, 1H), 7.98 (d, <i>J</i> = 1.50 Hz, 1H), 8.07–8.09 (d, <i>J</i> = 8.88 Hz, 1H). HPLC purity: 99.5%.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-chlorobenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-indazole (<b>18k</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). ESI mass: <i>m</i>/<i>e</i> 453, 455 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.41–1.53 (m, 2H), 2.10–2.18 (m, 5H), 2.49 (s, 3H), 2.66–2.72 (m, 2H), 3.55–3.57 (m, 3H), 4.53 (bs, 1H), 7.04–7.12 (m, 2H), 7.28–7.30 (m, 1H), 7.50–7.52 (d, <i>J</i> = 8.72 Hz, 1H), 7.73 (s, 1H), 8.07–8.10 (d, <i>J</i> = 8.84 Hz, 1H). HPLC purity: 94.7%.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-2,3-dihydrobenzo[1,4]oxazine (<b>18l</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3393, 2935, 1518, 1159. ESI mass: <i>m</i>/<i>e</i> 418 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.22–1.33 (m, 2H), 1.43–1.45 (m, 2H), 1.82–1.89 (m, 2H), 2.16 (s, 3H), 2.63–2.66 (m, 2H), 2.73–2.75 (m, 1H), 3.51–3.53 (t, <i>J</i> = 4.52 Hz, 2H), 3.75–3.77 (t, <i>J</i> = 4.52 Hz, 2H), 3.82 (s, 3H), 4.95–4.97 (d, <i>J</i> = 7.88 Hz, 1H), 6.23 (d, <i>J</i> = 1.53 Hz, 1H), 6.77–6.79 (dd, <i>J</i> = 8.15, 1.12 Hz, 1H), 6.91–6.98 (m, 3H), 7.06–7.10 (m, 1H), 7.73–7.75 (dd, <i>J</i> = 8.28, 1.26 Hz, 1H). HPLC purity: 99.6%.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-chloro-2,3-dihydrobenzo[1,4]oxazine (<b>18m</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3397, 2787, 1519, 1159. ESI mass: <i>m</i>/<i>e</i> 452, 454 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.29–1.39 (m, 2H), 1.48–1.51 (m, 2H), 1.91–1.96 (m, 2H), 2.20 (s, 3H), 2.69–2.72 (m, 2H), 2.81–2.82 (m, 1H), 3.53–3.55 (t, <i>J</i> = 4.52 Hz, 2H), 3.78–3.80 (t, <i>J</i> = 4.52 Hz, 2H), 3.85 (s, 3H), 5.07–5.09 (d, <i>J</i> = 7.79 Hz, 1H), 6.28 (d, <i>J</i> = 1.84 Hz, 1H), 6.84–6.87 (dd, <i>J</i> = 6.58, 2.22 Hz, 1H), 6.96–7.02 (m, 2H), 7.14–7.17 (dd, <i>J</i> = 8.79, 2.53 Hz, 1H), 7.77–7.78 (d, <i>J</i> = 2.52 Hz, 1H). HPLC purity: 99.2%.</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-fluoro-2,3-dihydrobenzo[1,4]oxazine (<b>18n</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3393, 2935, 1495, 1160. ESI mass: <i>m</i>/<i>e</i> 436 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.28–1.37 (m, 2H), 1.47–1.50 (m, 2H), 1.85–1.91 (m, 2H), 2.18 (s, 3H), 2.67–2.69 (m, 2H), 2.83–2.85 (m, 1H), 3.53–3.55 (t, <i>J</i> = 4.51 Hz, 2H), 3.78–3.80 (t, <i>J</i> = 4.46 Hz, 2H), 3.85 (s, 3H), 5.02–5.04 (d, <i>J</i> = 7.91 Hz, 1H), 6.33 (d, <i>J</i> = 1.98 Hz, 1H), 6.82–6.86 (m, 1H), 6.96–7.02 (m, 3H), 7.55–7.58 (dd, <i>J</i> = 10.78, 3.04 Hz, 1H). HPLC purity: 97.3%.</div></div><div id="sec5_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-methyl-2,3-dihydrobenzo[1,4]oxazine (<b>18o</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). ESI mass: <i>m</i>/<i>e</i> 432 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.57–1.65 (m, 2H), 1.82–1.87 (m, 2H), 2.32 (s, 6H), 2.62 (m, 2H), 3.15–3.24 (m, 2H), 3.54–3.56 (t, <i>J</i> = 4.77 Hz, 2H), 3.77–3.79 (t, <i>J</i> = 4.82 Hz, 2H), 3.89 (s, 3H), 4.27–4.29 (m, 1H), 6.43 (d, <i>J</i> = 1.95 Hz, 1H), 6.66–6.68 (d, <i>J</i> = 8.29 Hz, 1H), 6.75–6.77 (d, <i>J</i> = 8.38 Hz, 1H), 6.85–6.87 (d, <i>J</i> = 8.18 Hz, 1H), 7.07–7.10 (m, 1H), 7.73 (s, 1H). HPLC purity: 99.1%.</div></div><div id="sec5_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-trifluoromethyl-2,3-dihydrobenzo[1,4]oxazine (<b>18p</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). ESI mass: <i>m</i>/<i>e</i> 486 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.76–1.78 (m, 4H), 2.31–2.33 (m, 2H), 2.50 (s, 3H), 3.06–3.12 (m, 3H), 3.69–3.71 (t, <i>J</i> = 4.76 Hz, 2H), 3.84–3.87 (t, <i>J</i> = 4.82 Hz, 2H), 3.89 (s, 3H), 4.29–4.32 (m, 1H), 6.42 (d, <i>J</i> = 1.95 Hz, 1H), 6.76–6.78 (d, <i>J</i> = 8.38 Hz, 1H), 6.88–6.90 (d, <i>J</i> = 8.56 Hz, 1H), 7.07–7.10 (dd, <i>J</i> = 8.32, 2.03 Hz, 1H), 7.28–7.31 (dd, <i>J</i> = 8.66, 1.76 Hz, 1H), 8.26 (s, 1H). HPLC purity: 89.9%.</div></div><div id="sec5_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-fluoro-2,2-dimethyl-2,3-dihydrobenzo[1,4]oxazine (<b>18q</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3420, 2932, 1496, 1160. ESI mass: <i>m</i>/<i>e</i> 464 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.21 (s, 6H), 1.40–1.48 (m, 2H), 1.72–1.75 (m, 2H), 2.05–2.08 (m, 2H), 2.21 (s, 3H), 2.73–2.75 (m, 2H), 3.16–3.21 (m, 1H), 3.66 (s, 2H), 3.84 (s, 3H), 5.05–5.07 (d, <i>J</i> = 7.98 Hz, 1H), 6.78–6.83 (m, 3H), 6.97–6.99 (d, <i>J</i> = 8.44 Hz, 1H), 7.13–7.15 (dd, <i>J</i> = 8.36, 1.85 Hz, 1H), 7.44–7.46 (dd, <i>J</i> = 11.13, 1.58, Hz, 1H). HPLC purity: 97%.</div></div><div id="sec5_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-1,2,3,4-tetrahydroquinoline (<b>18r</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3423, 2940, 1518, 1157. ESI mass: <i>m</i>/<i>e</i> 416 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.36–1.39 (m, 2H), 1.54–1.57 (m, 2H), 1.72–1.75 (m, 2H), 2.00–2.01 (m, 2H), 2.30 (s, 3H), 2.41–2.44 (m, 2H), 2.76–2.79 (m, 2H), 3.0 (bs, 1H), 3.75–3.78 (m, 2H), 3.86 (s, 3H), 4.3 (bs, 1H), 6.41–6.42 (d, <i>J</i> = 2.0 Hz, 1H), 6.69–6.71 (d, <i>J</i> = 8.30 Hz, 1H), 6.96–7.00 (d, <i>J</i> = 7.3 Hz, 1H), 7.03–7.07 (m, 2H), 7.17–7.21 (m, 1H), 7.86–7.88 (d, <i>J</i> = 8.10 Hz, 1H). HPLC purity: 99.2%.</div></div><div id="sec5_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-[3-(1-Methylpiperidin-4-ylamino)-4-methoxybenzenesulfonyl]-1,2,3,4-tetrahydroisoquinoline (<b>18s</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>18</b> (Het = A, R<sup>1</sup> = OCH<sub>3</sub>, R<sup>2</sup> = CH<sub>3</sub>). IR (cm<sup>–1</sup>): 3425, 3020, 1597, 1216. ESI mass: <i>m</i>/<i>e</i> 416 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.60–1.65 (m, 2H), 2.01–2.07 (m, 2H), 2.17–2.31 (m, 4H), 2.39 (s, 3H), 2.89–2.91 (t, 3H), 3.34–3.37 (t, 2H), 3.89 (s, 3H), 4.27 (s, 2H), 4.30–4.32 (bs, 1H), 6.79–6.81 (d, <i>J</i> = 8.30 Hz, 1H), 6.91–6.92 (d, <i>J</i> = 1.90 Hz, 1H), 7.01–7.03 (m, 1H), 7.06–7.08 (m, 1H), 7.12 −7.16 (m, 3H). HPLC purity: 96.2%.</div></div><div id="sec5_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-[3-(Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine Hydrochloride (<b>19d</b>)</h4><div class="NLM_p">1-[3-(1-<i>tert</i>-Butyloxycarbonyl piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-chloro-3-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17</b>, Het = A, R<sup>1</sup> = OCH<sub>3</sub>, 0.5 g, 0.94 mmol) was stirred in isopropanolic HCl (20% w/v solution, 2.5 mL) for 2 h. After completion of the reaction (TLC), the solvent was removed in vacuo to obtain the title compound as white solids (0.35 g, 85% yield). ESI mass: <i>m</i>/<i>e</i> 435, 437 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ: 1.66–1.70 (m, 2H), 2.14–2.18 (m, 2H), 2.24 (s, 3H), 3.19–3.24 (m, 2H), 3.46–3.49 (m, 2H), 3.63–3.69 (m, 1H), 3.88 (s, 3H), 6.93–6.95 (d, <i>J</i> = 8.14 Hz, 1H), 7.37 (m, 2H), 7.61 (s, 1H), 8.01–8.02 (d, <i>J</i> = 2.08 Hz, 1H), 8.27–8.28 (d, <i>J</i> = 2.00 Hz, 1H). HPLC purity: 98.8%.</div><div class="NLM_p last">Compounds <b>19a</b>–<b>19c</b> and <b>19e</b> were prepared analogously.</div></div><div id="sec5_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-[3-(Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-6-fluoro-1<i>H</i>-indole Hydrochloride (<b>19a</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>19d</b>. IR (cm<sup>–1</sup>): 3428, 2952, 1602, 1433, 1284, 1168, 1179. ESI mass: <i>m</i>/<i>e</i> 404 (M + H)<sup>+</sup>. MR (°C): 203–205. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.57–1.63 (m, 2H), 1.80–1.83 (m, 2H), 3.01–3.07 (m, 2H), 3.21–3.24 (m, 2H), 3.63–3.67 (m, 1H), 3.78 (s, 3H), 3.79 (s, 1H), 6.77–6.78 (d, <i>J</i> = 3.52 Hz, 1H), 6.91–6.93 (d, <i>J</i> = 8.50 Hz, 1H), 7.02–7.03 (d, <i>J</i> = 2.16 Hz, 1H), 7.08–7.13 (m, 1H), 7.21–7.23 (dd, <i>J</i> = 8.45, 2.19 Hz, 1H), 7.57–7.61 (m, 1H), 7.75–7.79 (m, 2H), 8.49 (bs, 1H), 9.24 (bs, 1H). HPLC purity: 99%.</div></div><div id="sec5_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-[3-(Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-bromo-1<i>H</i>-indole Hydrochloride (<b>19b</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>19d</b>. IR (cm<sup>–1</sup>): 3422, 2955, 1600, 1433, 1374, 1168, 1179. ESI mass: <i>m</i>/<i>e</i> 464, 466 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 1.53–1.54 (m, 2H), 1.79–1.82 (m, 2H), 3.02–3.04 (m, 2H), 3.12–3.15 (m, 2H), 3.24–3.27 (m, 1H), 3.77 (s, 3H), 6.75–6.76 (d, <i>J</i> = 3.62 Hz, 1H), 6.90–6.92 (m, 2H), 7.17–7.20 (dd, <i>J</i> = 8.50, 2.24 Hz, 1H), 7.42–7.45 (dd, <i>J</i> = 8.46, 1.93 Hz, 1H), 7.80–7.84 (m, 2H), 7.93–7.95 (d, <i>J</i> = 8.84 Hz, 1H), 8.60 (bs, 1H), 8.90 (bs, 1H), 9.3 (bs, 1H). HPLC purity: 95%.</div></div><div id="sec5_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-[3-(Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-5-fluoro-1<i>H</i>-indole Hydrochloride (<b>19c</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>19d</b>. IR (cm<sup>–1</sup>): 3429, 2945, 1604, 1510, 1456, 1375, 1139. ESI mass: <i>m</i>/<i>e</i> 404 (M + H)<sup>+</sup>. MR (°C): 155–157. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.52–1.58 (m, 2H), 1.80–1.83 (m, 2H), 3.02–3.07 (m, 2H), 3.25–3.28 (m, 2H), 3.56–3.61 (m, 1H), 3.77 (s, 3H), 6.76–6.77 (m, 1H), 6.90–6.92 (d, <i>J</i> = 8.57 Hz, 1H), 6.93 (d, <i>J</i> = 2.28 Hz, 1H), 7.14–7.19 (m, 2H), 7.38–7.41 (dd, <i>J</i> = 9.10, 2.60 Hz, 1H), 7.85–7.86 (d, <i>J</i> = 3.65 Hz, 1H), 7.96–7.97 (m, 1H), 8.57 (s, 1H), 8.90 (s, 1H). HPLC purity: 98%.</div></div><div id="sec5_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-[3-(Piperidin-4-ylamino)-4-methoxybenzenesulfonyl]-1,2,3,4-tetrahydroquinoline Hydrochloride (<b>19e</b>)</h4><div class="NLM_p last">The title compound was prepared using essentially the same procedure as described for the preparation of <b>19d</b>. IR (cm<sup>–1</sup>): 3426, 1504, 1352, 1158. ESI mass: <i>m</i>/<i>e</i> 402 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.45–1.51 (m, 4H), 1.62 (m, 2H), 2.36–2.39 (t, 2H), 2.80–2.82 (m, 2H), 3.18–3.20 (d, 3H), 3.67–3.70 (m, 2H), 3.81 (s, 3H), 6.33–6.34 (d, <i>J</i> = 1.78 Hz, 1H), 6.91–6.97 (m, 2H), 7.03–7.09 (m, 2H), 7.14–7.19 (m, 1H), 7.67–7.69 (d, <i>J</i> = 8.0 Hz, 1H), 8.75–8.77 (bs, 1H), 8.90 (bs, 1H). HPLC purity: 99.8%.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78"><a href="/doi/suppl/10.1021/jm300955x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental protocols for the determination of <i>K</i><sub>b</sub> values for 5-HT<sub>6</sub> receptor, dofetilide binding hERG assay, microsomal metabolic and CYP 3A4 and 2D6 inhibition protocol, pharmacokinetic study in rats and dogs, rodent brain penetration study, in vivo brain microdialysis and object recognition task. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300955x/suppl_file/jm300955x_si_001.pdf">jm300955x_si_001.pdf (142.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300955x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramakrishna Nirogi</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b3ddc5c0c1d8f3c0c6c5d6dd9dd0dcde"><span class="__cf_email__" data-cfemail="513f2722233a11222427343f7f323e3c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil Shinde</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anand Daulatabad</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramasastri Kambhampati</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Parandhama Gudla</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammad Shaik</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muralimohan Gampa</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suresh Balasubramaniam</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamuletinarasimhareddy Gangadasari</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veena Reballi</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajeshkumar Badange</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kumar Bojja</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Medicinal
Chemistry, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramkumar Subramanian</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—In
Vitro Biology, Suven Life Sciences Ltd., Serene Chambers, Road-5,
Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gopinadh Bhyrapuneni</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Drug
Metabolism and Phamacokinetics, Suven Life Sciences Ltd., Serene Chambers,
Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nageswararao Muddana</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—Drug
Metabolism and Phamacokinetics, Suven Life Sciences Ltd., Serene Chambers,
Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradeep Jayarajan</span> - <span class="hlFld-Affiliation affiliation">Discovery Research—In
Vivo Biology, Suven Life Sciences Ltd., Serene Chambers, Road-5, Avenue-7,
Banjara Hills, Hyderabad 500 034, India</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3088e6906-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The support received from Discovery Analytical Department, and Venkateswarlu Jasti, CEO, Suven Life Sciences Ltd., Hyderabad, is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">5-HT<sub>6</sub>R</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 6 receptor</p></td></tr><tr><td class="NLM_term">ORT</td><td class="NLM_def"><p class="first last">object recognition test</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptors</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Alzheimer's Disease International; <a href="http://www.alz.co.uk" class="extLink">http://www.alz.co.uk</a> (accessed 11 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%27s+Disease+International%3B+http%3A%2F%2Fwww.alz.co.uk+%28accessed+11+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Disease%2520International" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, A. K.</span><span> </span><span class="NLM_article-title">Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=1555-1561&author=R.+S.+Doodyauthor=S.+H.+Ferrisauthor=S.+Sallowayauthor=Y.+Sunauthor=R.+Goldmanauthor=W.+E.+Watkinsauthor=Y.+Xuauthor=A.+K.+Murthy&title=Donepezil+treatment+of+patients+with+MCI%3A+a+48-week+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DFerris%26aufirst%3DS.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DGoldman%26aufirst%3DR.%26aulast%3DWatkins%26aufirst%3DW.%2BE.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMurthy%26aufirst%3DA.%2BK.%26atitle%3DDonepezil%2520treatment%2520of%2520patients%2520with%2520MCI%253A%2520a%252048-week%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26spage%3D1555%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Effective Pharmacologic Management of Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2Fj.amjmed.2006.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=17466645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslWku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=388-397&author=M.+R.+Farlowauthor=J.+L.+Cummings&title=Effective+Pharmacologic+Management+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Pharmacologic Management of Alzheimer's Disease</span></div><div class="casAuthors">Farlow, Martin R.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  To assist physicians in the effective pharmacol. management of this challenging population, evidence-based pharmacol. treatment algorithms for the different stages of Alzheimer's disease have been developed.  Evidence-based guidelines outlining pharmacotherapeutic strategies can be systematically implemented to optimize outcomes for patients in different stages of Alzheimer's disease.  The first step toward the best possible long-term management is early diagnosis of Alzheimer's disease, thereby facilitating early initiation of cholinesterase inhibitor treatment, which may stabilize/reduce the rate of symptomatic cognitive and functional decline.  Cholinesterase inhibitor therapy with rivastigmine, donepezil, or galantamine is endorsed as std. first-line therapy in patients with mild-to-moderate Alzheimer's disease.  The N-methyl-D-aspartate receptor-antagonist, memantine, may be used as monotherapy or in combination with a cholinesterase inhibitor for patients with moderate Alzheimer's disease, and as monotherapy for patients with severe Alzheimer's disease.  During treatment, cognitive and functional status should be monitored over 6-mo intervals, and pharmacol. therapy should ideally be continued until there are no meaningful social interactions and quality of life has irreversibly deteriorated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeKXzhxyprLLVg90H21EOLACvtfcHk0lhaAAiCqIcLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslWku7s%253D&md5=e13b2635e1ee76f5ecbca133876da4bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DEffective%2520Pharmacologic%2520Management%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D388%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Update on the use of memantine in Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.2147%2FNDT.S4048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=19557118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSks77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=237-247&author=R.+J.+Van+Marum&title=Update+on+the+use+of+memantine+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the use of memantine in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-247</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Memantine is a low to moderate affinity N-methyl--aspartate receptor (NMDAR) antagonist.  The effects of memantine in Alzheimer's disease (AD) have been studied in 7 randomized controlled trials in many post-hoc analyses.  Three out of four RCTs in patients with moderate to severe AD (Mini Mental State Examn. [MMSE] <14) showed a statistically significant but clin. small pos. effect of memantine on cognition, global functioning, activities of daily living (ADL) and neuropsychiatric symptoms.  No effects on these outcome measures could be found in the three RCTs studying patients with mild to moderate AD (MMSE 14-24).  Two of these studies evaluated the effect of addn. of memantine to donepezil.  Only the study in patients with mild to moderate AD showed a pos. effect of addn. of memantine on cognition, ADL, global functioning and neuropsychiatric functioning.  Cost-effectiveness of memantine therapy remains controversial.  Post-hoc analyses and observational studies suggest some effects on agitation/aggression, delusions or hallucinations.  Side effects of memantine are usually mild and seem to be comparable with placebo.  In this review, an oversight of pharmacodynamics and pharmacokinetics of memantine is presented.  Also, published data concerning efficacy and safety in patients with AD are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqjRpQ6xBtbVg90H21EOLACvtfcHk0lhaAAiCqIcLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSks77L&md5=b49108d6f4956f51f7429513a792edb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2147%2FNDT.S4048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S4048%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DUpdate%2520on%2520the%2520use%2520of%2520memantine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2009%26volume%3D5%26spage%3D237%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sebben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansanay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptors positively coupled to adenylyl cyclase in striatal neurones in culture</span> <span class="citation_source-journal">Neuroreport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=2553-2557&author=M.+Sebbenauthor=H.+Ansanayauthor=J.+Bockaertauthor=A.+Dumuis&title=5-HT6+receptors+positively+coupled+to+adenylyl+cyclase+in+striatal+neurones+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebben%26aufirst%3DM.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT6%2520receptors%2520positively%2520coupled%2520to%2520adenylyl%2520cyclase%2520in%2520striatal%2520neurones%2520in%2520culture%26jtitle%3DNeuroreport%26date%3D1994%26volume%3D5%26spage%3D2553%26epage%3D2557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C. F.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=59-79&author=M.+L.+Woolleyauthor=C.+A.+Marsdenauthor=K.+C.+F.+Fone&title=5-HT6+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">5-ht6 receptors</span></div><div class="casAuthors">Woolley, Marie L.; Marsden, Charles A.; Fone, Kevin C. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-79</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-hydroxytryptamine6 (5-ht6) was 1 of the most recent addns. to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent.  The high affinity of a wide range of psychiatric drugs for the 5-ht6 receptor, together with its almost exclusive expression in the central nervous system, being abundant in limbic and cortical regions, has stimulated significant research interest.  The 5-ht6 receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures.  The current article will review all aspects of the discovery, genetics, distribution, pharmacol., and function of the 5-ht6 receptor.  Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht6 receptor to be approved and its true status recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK0SUNoG7ubVg90H21EOLACvtfcHk0lh0oQ-3CpHEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D&md5=3883fe6d1a7764bf81a6b22e255fbf4d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%2BF.%26atitle%3D5-HT6%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2004%26volume%3D3%26spage%3D59%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span> </span><span class="NLM_article-title">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=7680751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=320-327&author=F.+J.+Monsmaauthor=Y.+Shenauthor=R.+P.+Wardauthor=M.+W.+Hamblinauthor=D.+R.+Sibley&title=Cloning+and+expression+of+a+novel+serotonin+receptor+with+high+affinity+for+tricyclic+psychotropic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span></div><div class="casAuthors">Monsma, Frederick J., Jr.; Shen, Yong; Ward, Raymond P.; Hamblin, Mark W.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The polymerase chain reaction technique was used to selectively amplify a guanine nucleotide-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homol. to previously cloned serotonin receptors.  Sequencing of a full length clone isolated from a rat striatal cDNA library revealed an open reading frame of 1311 base pairs, encoding a 437-residue protein with 7 hydrophobic regions.  Within these hydrophobic regions, this receptor was 36-41% identical to the following serotonin (5-HT) receptors: 5-HT2 > 5-HT1D > 5-HT1C > 5-HT1B > 5-HT1A > 5-HT1E.  Northern blots revealed a ∼4.2-kilobase transcript localized in various brain regions, with the following rank order of abundance: striatum » olfactory tubercle > cerebral cortex > hippocampus.  Expression of this clone in COS-7 cells resulted in the appearance of high affinity, saturable binding of (+)-[2-125I]iodolyzergic acid diethylamide ([125I]LSD) with a Kd of 1.26 nM.  Among endogenous biogenic amines, only 5-HT completely inhibited [125I]LSD binding (Ki = 150 nM).  The inhibition of [125I]LSD binding by other serotonergic agonists and antagonists revealed a pharmacol. profile that does not correlate with that of any previously described serotonin receptor subtype.  In addn., this receptor exhibits high affinity for a no. of tricyclic antipsychotic and antidepressant drugs, including clozapine, amoxipine, and amitriptyline.  In HEK-293 cells stably transfected with this receptor, serotonin elicits a potent stimulation of adenylyl cyclase activity, which is blocked by antipsychotic and antidepressant drugs.  The distinct structural and pharmacol. properties of this receptor site indicate that it represents a completely novel subtype of serotonin receptor.  Based on its affinity for tricyclic psychotropic drugs and its localization to limbic and cortical regions of the brain, it is likely that this receptor may play a role in several neuropsychiatric disorders that involve serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktsaVgvzJ9LVg90H21EOLACvtfcHk0lh0oQ-3CpHEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D&md5=c8b46ab9e3591b6ea473459f18f006ea</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWard%26aufirst%3DR.%2BP.%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520novel%2520serotonin%2520receptor%2520with%2520high%2520affinity%2520for%2520tricyclic%2520psychotropic%2520drugs%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> antagonists as potential treatment for cognitive dysfunction</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=145-168&author=K.+G.+Liuauthor=A.+J.+Robichaud&title=5-HT6+antagonists+as+potential+treatment+for+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3D5-HT6%2520antagonists%2520as%2520potential%2520treatment%2520for%2520cognitive%2520dysfunction%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D145%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Witty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T. T.</span><span> </span><span class="NLM_article-title">Advances in the design of 5-HT<sub>6</sub> receptor ligands with therapeutic potential</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2FS0079-6468%2809%2904805-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=21544960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVegs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=163-224&author=D.+Wittyauthor=M.+Ahmedauthor=T.+T.+Chuang&title=Advances+in+the+design+of+5-HT6+receptor+ligands+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the design of 5-HT6 receptor ligands with therapeutic potential</span></div><div class="casAuthors">Witty, David; Ahmed, Mahmood; Chuang, Tsu Tshen</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-224</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on recent advances in the discovery, optimization and exploiting the serotonin (5-hydroxytryptamine, 5-HT) 6 receptor ligands.  The focus is on scientific publications and patent applications describing new chem. series published since 2005.  In addn. to 5-HT6 receptor modulation, approaches targeting dual 5-HT6 and second receptor modulation are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnyxjAIXLXRrVg90H21EOLACvtfcHk0lh0oQ-3CpHEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVegs70%253D&md5=2d263999d1f49c5df128e528af4edb57</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2809%2904805-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252809%252904805-X%26sid%3Dliteratum%253Aachs%26aulast%3DWitty%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26atitle%3DAdvances%2520in%2520the%2520design%2520of%25205-HT6%2520receptor%2520ligands%2520with%2520therapeutic%2520potential%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D163%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siripurapu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">The Medicinal Chemistry of 5-HT<sub>6</sub> Receptor Ligands with a Focus on Arylsulfonyltryptamine Analogs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.2174%2F156802610791111542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=20166945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=579-595&author=R.+A.+Glennonauthor=U.+Siripurapuauthor=B.+L.+Rothauthor=R.+Kolanosauthor=M.+L.+Bondarevauthor=D.+Sikazweauthor=M.+Leeauthor=M.+Dukat&title=The+Medicinal+Chemistry+of+5-HT6+Receptor+Ligands+with+a+Focus+on+Arylsulfonyltryptamine+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs</span></div><div class="casAuthors">Glennon, Richard A.; Siripurapu, Uma; Roth, Bryan L.; Kolanos, Renata; Bondarev, Mikhail L.; Sikazwe, Donald; Lee, Mase; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines (e.g. MS-245; 5) were described as the first examples of selective 5-HT6 receptor antagonists only ten years ago.  Today, hundreds of compds. of seemingly diverse structure have been reported.  The early antagonists featured an arylsulfonyl group leading to the widespread assumption that an arylsulfonyl moiety might be crit. for binding and antagonist action.  With respect to the arylsulfonyltryptamines, it seems that neither the "arylsulfonyl" nor the "tryptamine" portion of these compds. is essential for binding or for antagonist action, and some such derivs. even display agonist action.  The present review describes many of the currently available 5-HT6 receptor ligands and, unlike prior reviews, provides a narrative of the thinking (where possible) that led to their design, synthesis, and evaluation.  The arylsulfonyltryptamines are also used as the structural basis of attempts to relate various structure-types to one another to afford a better understanding of the overall structural requirements for 5-HT6 receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcIaCOtbRK7Vg90H21EOLACvtfcHk0li47NpNNVBPaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D&md5=c9aac49fd24a4bc84f478db4217073d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802610791111542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791111542%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSiripurapu%26aufirst%3DU.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DThe%2520Medicinal%2520Chemistry%2520of%25205-HT6%2520Receptor%2520Ligands%2520with%2520a%2520Focus%2520on%2520Arylsulfonyltryptamine%2520Analogs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodgson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassam, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P.</span><span> </span><span class="NLM_article-title">5-Chloro-<i>N</i>-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon-amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT<sub>6</sub> Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980532e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=202-205&author=S.+M.+Bromidgeauthor=A.+M.+Brownauthor=S.+E.+Clarkeauthor=K.+Dodgsonauthor=T.+Gagerauthor=H.+L.+Grassamauthor=P.+M.+Jeffreyauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=D.+N.+Middlemissauthor=S.+F.+Mossauthor=H.+Newmanauthor=G.+Rileyauthor=C.+Routledgeauthor=P.+Wyman&title=5-Chloro-N-%284-methoxy-3-piperazin-1-yl-+phenyl%29-3-methyl-2-benzothiophenesulfon-amide+%28SB-271046%29%3A+A+Potent%2C+Selective%2C+and+Orally+Bioavailable+5-HT6+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm980532e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980532e%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DDodgson%26aufirst%3DK.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DGrassam%26aufirst%3DH.%2BL.%26aulast%3DJeffrey%26aufirst%3DP.%2BM.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DNewman%26aufirst%3DH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DWyman%26aufirst%3DP.%26atitle%3D5-Chloro-N-%25284-methoxy-3-piperazin-1-yl-%2520phenyl%2529-3-methyl-2-benzothiophenesulfon-amide%2520%2528SB-271046%2529%253A%2520A%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%25205-HT6%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D202%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winbornc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, D. R.</span><span> </span><span class="NLM_article-title">Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4867-4871&author=M.+Ahmedauthor=M.+A.+Briggsauthor=S.+M.+Bromidgeauthor=T.+Buckauthor=L.+Campbellauthor=N.+J.+Deeksauthor=A.+Garnerauthor=L.+Gordonauthor=D.+W.+Hamprechtauthor=V.+Hollandauthor=C.+N.+Johnsonauthor=A.+D.+Medhurstauthor=D.+J.+Mitchellauthor=S.+F.+Mossauthor=J.+Powlesauthor=J.+T.+Sealauthor=T.+O.+Steanauthor=G.+Stempauthor=M.+Thompsonauthor=B.+Trailauthor=N.+Uptonauthor=K.+Winborncauthor=D.+R.+Witty&title=Bicyclic+heteroarylpiperazines+as+selective+brain+penetrant+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBuck%26aufirst%3DT.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DGarner%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DHamprecht%26aufirst%3DD.%2BW.%26aulast%3DHolland%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DPowles%26aufirst%3DJ.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DTrail%26aufirst%3DB.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DWinbornc%26aufirst%3DK.%26aulast%3DWitty%26aufirst%3DD.%2BR.%26atitle%3DBicyclic%2520heteroarylpiperazines%2520as%2520selective%2520brain%2520penetrant%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4867%26epage%3D4871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span>. <span class="NLM_contrib-group">Brmoidge, S. M.</span><span> </span><span class="NLM_article-title">Indolesulfonyl compounds useful in the treatment of CNS disorders</span>. WO2002041889,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.+M.+Brmoidge&title=Indolesulfonyl+compounds+useful+in+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrmoidge%26aufirst%3DS.%2BM.%26atitle%3DIndolesulfonyl%2520compounds%2520useful%2520in%2520the%2520treatment%2520of%2520CNS%2520disorders%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>GlaxoSmithKline; <a href="http://www.gsk.com" class="extLink">http://www.gsk.com</a> (accessed 11 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline%3B+http%3A%2F%2Fwww.gsk.com+%28accessed+11+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGlaxoSmithKline" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Lundbeck; <a href="http://www.lundbeck.com/global" class="extLink">http://www.lundbeck.com/global</a> (accessed 1 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lundbeck%3B+http%3A%2F%2Fwww.lundbeck.com%2Fglobal+%28accessed+1+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DLundbeck" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mads, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joanna, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soren, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mette, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louise, M. W.</span><span> </span><span class="NLM_article-title">Lu AE58054, a 5-HT<sub>6</sub> antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1017%2FS1461145710000659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=20569520" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1021-1033&author=A.+Jornauthor=B.+Bennyauthor=G.+Benauthor=P.+B.+Franklinauthor=P.+C.+Michaelauthor=W.+D.+Neilauthor=G.+Brunoauthor=K.+Madsauthor=L.+M.+Davidauthor=C.+N.+Joannaauthor=L.+N.+Davidauthor=M.+N.+Sorenauthor=N.+P.+Metteauthor=M.+S.+Johnauthor=M.+W.+Louise&title=Lu+AE58054%2C+a+5-HT6+antagonist%2C+reverses+cognitive+impairment+induced+by+subchronic+phencyclidine+in+a+novel+object+recognition+test+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000659%26sid%3Dliteratum%253Aachs%26aulast%3DJorn%26aufirst%3DA.%26aulast%3DBenny%26aufirst%3DB.%26aulast%3DBen%26aufirst%3DG.%26aulast%3DFranklin%26aufirst%3DP.%2BB.%26aulast%3DMichael%26aufirst%3DP.%2BC.%26aulast%3DNeil%26aufirst%3DW.%2BD.%26aulast%3DBruno%26aufirst%3DG.%26aulast%3DMads%26aufirst%3DK.%26aulast%3DDavid%26aufirst%3DL.%2BM.%26aulast%3DJoanna%26aufirst%3DC.%2BN.%26aulast%3DDavid%26aufirst%3DL.%2BN.%26aulast%3DSoren%26aufirst%3DM.%2BN.%26aulast%3DMette%26aufirst%3DN.%2BP.%26aulast%3DJohn%26aufirst%3DM.%2BS.%26aulast%3DLouise%26aufirst%3DM.%2BW.%26atitle%3DLu%2520AE58054%252C%2520a%25205-HT6%2520antagonist%252C%2520reverses%2520cognitive%2520impairment%2520induced%2520by%2520subchronic%2520phencyclidine%2520in%2520a%2520novel%2520object%2520recognition%2520test%2520in%2520rats%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D13%26spage%3D1021%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Nirogi, R. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daulatabad, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parandhama, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastri, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubey, P. K.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4440</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4440-4443&author=R.+V.+S.+Nirogiauthor=A.+V.+Daulatabadauthor=G.+Parandhamaauthor=S.+Mohammadauthor=K.+R.+Sastriauthor=A.+K.+Shindeauthor=P.+K.+Dubey&title=Synthesis+and+pharmacological+evaluation+of+aryl+aminosulfonamide+derivatives+as+potent+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%2BV.%2BS.%26aulast%3DDaulatabad%26aufirst%3DA.%2BV.%26aulast%3DParandhama%26aufirst%3DG.%26aulast%3DMohammad%26aufirst%3DS.%26aulast%3DSastri%26aufirst%3DK.%2BR.%26aulast%3DShinde%26aufirst%3DA.%2BK.%26aulast%3DDubey%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520aryl%2520aminosulfonamide%2520derivatives%2520as%2520potent%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4440%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethofer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrova, L.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzo[1,4]oxazine derivatives as 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3504</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3504-3507&author=S.+H.+Zhaoauthor=J.+Bergerauthor=R.+D.+Clarkauthor=S.+G.+Sethoferauthor=N.+E.+Kraussauthor=J.+M.+Brothersauthor=R.+S.+Martinauthor=D.+L.+Misnerauthor=D.+Schwabauthor=L.+Alexandrova&title=3%2C4-Dihydro-2H-benzo%5B1%2C4%5Doxazine+derivatives+as+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%2BH.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DSethofer%26aufirst%3DS.%2BG.%26aulast%3DKrauss%26aufirst%3DN.%2BE.%26aulast%3DBrothers%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DR.%2BS.%26aulast%3DMisner%26aufirst%3DD.%2BL.%26aulast%3DSchwab%26aufirst%3DD.%26aulast%3DAlexandrova%26aufirst%3DL.%26atitle%3D3%252C4-Dihydro-2H-benzo%255B1%252C4%255Doxazine%2520derivatives%2520as%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3504%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baddeley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khazragi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, D. R.</span><span> </span><span class="NLM_article-title">Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5698</span><span class="NLM_x">–</span> <span class="NLM_lpage">5700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5698-5700&author=G.+Traniauthor=S.+M.+Baddeleyauthor=M.+A.+Briggsauthor=T.+T.+Chuangauthor=N.+J.+Deeksauthor=C.+N.+Johnsonauthor=A.+A.+Khazragiauthor=T.+L.+Meadauthor=A.+D.+Medhurstauthor=P.+H.+Milnerauthor=L.+P.+Quinnauthor=A.+M.+Rayauthor=D.+A.+Riversauthor=T.+O.+Steanauthor=G.+Stempauthor=B.+K.+Trailauthor=D.+R.+Witty&title=Tricyclic+azepine+derivatives+as+selective+brain+penetrant+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrani%26aufirst%3DG.%26aulast%3DBaddeley%26aufirst%3DS.%2BM.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DKhazragi%26aufirst%3DA.%2BA.%26aulast%3DMead%26aufirst%3DT.%2BL.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMilner%26aufirst%3DP.%2BH.%26aulast%3DQuinn%26aufirst%3DL.%2BP.%26aulast%3DRay%26aufirst%3DA.%2BM.%26aulast%3DRivers%26aufirst%3DD.%2BA.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DB.%2BK.%26aulast%3DWitty%26aufirst%3DD.%2BR.%26atitle%3DTricyclic%2520azepine%2520derivatives%2520as%2520selective%2520brain%2520penetrant%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5698%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafinowska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span> </span><span class="NLM_article-title">Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of <i>N</i>-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=55-58&author=S.+M.+Bromidgeauthor=S.+E.+Clarkeauthor=T.+Gagerauthor=K.+Griffithauthor=P.+Jeffreyauthor=A.+J.+Jenningsauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=P.+J.+Lovellauthor=S.+F.+Mossauthor=H.+Newmanauthor=G.+Rileyauthor=D.+Rogersauthor=C.+Routledgeauthor=H.+Serafinowskaauthor=D.+R.+Smith&title=Phenyl+benzenesulfonamides+are+novel+and+selective+5-HT6+antagonists%3A+identification+of+N-%282%2C5-dibromo-3-fluorophenyl%29-4-methoxy-3-piperazin-1-ylbenzenesulfonamide+%28SB-357134%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DGriffith%26aufirst%3DK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DNewman%26aufirst%3DH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DSerafinowska%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26atitle%3DPhenyl%2520benzenesulfonamides%2520are%2520novel%2520and%2520selective%25205-HT6%2520antagonists%253A%2520identification%2520of%2520N-%25282%252C5-dibromo-3-fluorophenyl%2529-4-methoxy-3-piperazin-1-ylbenzenesulfonamide%2520%2528SB-357134%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ruth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucy, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doris, E. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chris, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, W. H.</span><span> </span><span class="NLM_article-title">Cloning of the mouse 5-HT<sub>6</sub> serotonin receptor and mutagenesis studies of the third cytoplasmic loop</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2FS0169-328X%2801%2900090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=11406289" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=110-117&author=K.+Ruthauthor=A.+F.+Lucyauthor=E.+A.+H.+Dorisauthor=R.+G.+Chrisauthor=W.+H.+Mark&title=Cloning+of+the+mouse+5-HT6+serotonin+receptor+and+mutagenesis+studies+of+the+third+cytoplasmic+loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2801%2900090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252801%252900090-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuth%26aufirst%3DK.%26aulast%3DLucy%26aufirst%3DA.%2BF.%26aulast%3DDoris%26aufirst%3DE.%2BA.%2BH.%26aulast%3DChris%26aufirst%3DR.%2BG.%26aulast%3DMark%26aufirst%3DW.%2BH.%26atitle%3DCloning%2520of%2520the%2520mouse%25205-HT6%2520serotonin%2520receptor%2520and%2520mutagenesis%2520studies%2520of%2520the%2520third%2520cytoplasmic%2520loop%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2001%26volume%3D90%26spage%3D110%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gonzalo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elisabeth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmut, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrus, J. P.</span><span> </span><span class="NLM_article-title">Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1038%2Fsj.bjp.0706827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=16865095" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=1133-1143&author=R.+Gonzaloauthor=S.+Elisabethauthor=P.+Martaauthor=P.+Pilarauthor=C.+Xavierauthor=H.+Jorgauthor=B.+Helmutauthor=J.+P.+Petrus&title=Efficacy+of+selective+5-HT6+receptor+ligands+determined+by+monitoring+5-HT6+receptor-mediated+cAMP+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706827%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalo%26aufirst%3DR.%26aulast%3DElisabeth%26aufirst%3DS.%26aulast%3DMarta%26aufirst%3DP.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DXavier%26aufirst%3DC.%26aulast%3DJorg%26aufirst%3DH.%26aulast%3DHelmut%26aufirst%3DB.%26aulast%3DPetrus%26aufirst%3DJ.%2BP.%26atitle%3DEfficacy%2520of%2520selective%25205-HT6%2520receptor%2520ligands%2520determined%2520by%2520monitoring%25205-HT6%2520receptor-mediated%2520cAMP%2520signaling%2520pathways%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D1133%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Anglade, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enjuanes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morillon., D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drieu la Rochelle, C.</span><span> </span><span class="NLM_article-title">The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2Fj.vascn.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=16750402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=99-105&author=V.+B.+Angladeauthor=E.+Enjuanesauthor=D.+Morillon.author=C.+Drieu+la+Rochelle&title=The+object+recognition+task+in+rats+and+mice%3A+a+simple+and+rapid+model+in+safety+pharmacology+to+detect+amnesic+properties+of+a+new+chemical+entity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DAnglade%26aufirst%3DV.%2BB.%26aulast%3DEnjuanes%26aufirst%3DE.%26aulast%3DMorillon.%26aufirst%3DD.%26aulast%3DDrieu%2Bla%2BRochelle%26aufirst%3DC.%26atitle%3DThe%2520object%2520recognition%2520task%2520in%2520rats%2520and%2520mice%253A%2520a%2520simple%2520and%2520rapid%2520model%2520in%2520safety%2520pharmacology%2520to%2520detect%2520amnesic%2520properties%2520of%2520a%2520new%2520chemical%2520entity%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Takashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryo, F.</span><span> </span><span class="NLM_article-title">Drug Induced Phospholipidosis—Pathological Aspects and its Prediction</span> <span class="citation_source-journal">J. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1293%2Ftox.21.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=9-24&author=N.+Takashiauthor=F.+Ryo&title=Drug+Induced+Phospholipidosis%E2%80%94Pathological+Aspects+and+its+Prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1293%2Ftox.21.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1293%252Ftox.21.9%26sid%3Dliteratum%253Aachs%26aulast%3DTakashi%26aufirst%3DN.%26aulast%3DRyo%26aufirst%3DF.%26atitle%3DDrug%2520Induced%2520Phospholipidosis%25E2%2580%2594Pathological%2520Aspects%2520and%2520its%2520Prediction%26jtitle%3DJ.%2520Toxicol.%2520Pathol.%26date%3D2008%26volume%3D21%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lirHvmZH-tW5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nirogi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhyrapuneni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandikere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benade, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muddana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irappanavar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnamaneni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkanti, K.</span><span> </span><span class="NLM_article-title">Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1007%2Fs13318-012-0081-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Omur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=155-161&author=R.+Nirogiauthor=G.+Bhyrapuneniauthor=V.+Kandikereauthor=V.+Benadeauthor=N.+Muddanaauthor=R.+Saralayaauthor=S.+Irappanavarauthor=R.+Ponnamaneniauthor=K.+Mukkanti&title=Concurrent+administration+of+atypical+antipsychotics+and+donepezil%3A+drug+interaction+study+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats</span></div><div class="casAuthors">Nirogi, Ramakrishna; Bhyrapuneni, Gopinadh; Kandikere, Vishwottam; Benade, Vijay; Muddana, Nageswararao; Saralaya, Ramanatha; Irappanavar, Shantaveer; Ponnamaneni, Ranjithkumar; Mukkanti, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-161</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Psychotic and behavioral symptoms are common in patients with dementia.  Thus, it is rational to assume that patients with dementia would gain benefit from combination therapy of an antipsychotic agent and a cognitive enhancer.  Antipsychotics are not approved by the US FDA in elderly patients with dementia but their use is still prevalent in other population.  In the current study, we investigate the effect of atypical antipsychotics on acetylcholine modulation by donepezil.  In addn., the plasma pharmacokinetics on concurrent administration of these drugs was studied.  Acetylcholine modulation was carried out in the ventral hippocampus of Sprague-Dawley rats using brain microdialysis technique.  In a parallel group of animals, pharmacokinetic parameters were evaluated on administration of donepezil (5.0 mg kg-1, i.p.) alone and in combination with olanzapine, clozapine, or quetiapine.  Donepezil produced 348% increase in hippocampal acetylcholine levels.  Coadministration of olanzapine and donepezil produced 393% increase in extracellular acetylcholine, and the effect was supported by a significantly (p < 0.05) decreased clearance of donepezil in plasma.  Whereas, other plasma pharmacokinetic parameters of donepezil "AUC0-24h, T 1/2 and T max" were moderately altered after this combination treatment.  Concurrent administrations of clozapine or quetiapine with donepezil produced a non-significant change in acetylcholine levels in comparison to donepezil alone.  The plasma pharmacokinetics of donepezil was unaltered.  Results from this preclin. investigation indicate that extrapyramidal side effects may ppt. upon coadministration of donepezil with olanzapine.  Care must be exercised by physicians and caregivers while administering these two drugs together.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXWjvJN-HlrVg90H21EOLACvtfcHk0licAMwTqxEXaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Omur7J&md5=5c2d688bed1f49ea55d655e2b2521379</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs13318-012-0081-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-012-0081-1%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DIrappanavar%26aufirst%3DS.%26aulast%3DPonnamaneni%26aufirst%3DR.%26aulast%3DMukkanti%26aufirst%3DK.%26atitle%3DConcurrent%2520administration%2520of%2520atypical%2520antipsychotics%2520and%2520donepezil%253A%2520drug%2520interaction%2520study%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D37%26spage%3D155%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Paxinos, G.; Watson, C.</span> In  <span class="citation_source-book">Rat Brain in Stereotaxic Coordinates</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Paxinos&author=C.+Watson&title=Rat+Brain+in+Stereotaxic+Coordinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaxinos%26aufirst%3DG.%26btitle%3DRat%2520Brain%2520in%2520Stereotaxic%2520Coordinates%26pub%3DAcademic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Batcho, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimgruber, W.</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Batcho%2C+A.+D.%3B+Leimgruber%2C+W.Org.+Synth.+1985%2C+63%2C+214%E2%80%93220"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatcho%26aufirst%3DA.%2BD.%26aulast%3DLeimgruber%26aufirst%3DW.%26jtitle%3DOrg.%2520Synth.%26date%3D1985%26volume%3D63%26spage%3D214%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">An effective procedure for the preparation of 3-substituted-4- or 6-azaindoles from <i>ortho</i>-methyl nitro pyridines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=5653-5656&author=J.+Zhuauthor=H.+Wongauthor=Z.+Zhangauthor=Z.+Yinauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=An+effective+procedure+for+the+preparation+of+3-substituted-4-+or+6-azaindoles+from+ortho-methyl+nitro+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DAn%2520effective%2520procedure%2520for%2520the%2520preparation%2520of%25203-substituted-4-%2520or%25206-azaindoles%2520from%2520ortho-methyl%2520nitro%2520pyridines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span>. <span class="NLM_contrib-group">Bonhaus, D. W.; Martin, R. S.; Sethofer, S.; Zhang, L.; Zhao, S.</span><span> </span><span class="NLM_article-title">Benzoxazine and quinoxaline derivatives and uses</span>. WO 2006037481 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+W.+Bonhaus&author=R.+S.+Martin&author=S.+Sethofer&author=L.+Zhang&author=S.+Zhao&title=Benzoxazine+and+quinoxaline+derivatives+and+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26atitle%3DBenzoxazine%2520and%2520quinoxaline%2520derivatives%2520and%2520uses%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramakrishna  Nirogi</span>, <span class="hlFld-ContribAuthor ">Anil  Shinde</span>, <span class="hlFld-ContribAuthor ">Rama Sastry  Kambhampati</span>, <span class="hlFld-ContribAuthor ">Abdul Rasheed  Mohammed</span>, <span class="hlFld-ContribAuthor ">Sangram Keshari  Saraf</span>, <span class="hlFld-ContribAuthor ">Rajesh kumar  Badange</span>, <span class="hlFld-ContribAuthor ">Thrinath Reddy  Bandyala</span>, <span class="hlFld-ContribAuthor ">Venugopalarao  Bhatta</span>, <span class="hlFld-ContribAuthor ">Kumar  Bojja</span>, <span class="hlFld-ContribAuthor ">Veena  Reballi</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Subramanian</span>, <span class="hlFld-ContribAuthor ">Vijay  Benade</span>, <span class="hlFld-ContribAuthor ">Raghava Choudary  Palacharla</span>, <span class="hlFld-ContribAuthor ">Gopinadh  Bhyrapuneni</span>, <span class="hlFld-ContribAuthor ">Pradeep  Jayarajan</span>, <span class="hlFld-ContribAuthor ">Vinod  Goyal</span>, and <span class="hlFld-ContribAuthor ">Venkat  Jasti</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1843-1859. <a href="https://doi.org/10.1021/acs.jmedchem.6b01662" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252B1-%25255B%2525282-Bromophenyl%252529sulfonyl%25255D-5-methoxy-3-%25255B%2525284-methyl-1-piperazinyl%252529methyl%25255D-1H-indole%252BDimesylate%252BMonohydrate%252B%252528SUVN-502%252529%25253A%252BA%252BNovel%25252C%252BPotent%25252C%252BSelective%252Band%252BOrally%252BActive%252BSerotonin%252B6%252B%2525285-HT6%252529%252BReceptor%252BAntagonist%252Bfor%252BPotential%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D11112016%26date%3D17022017%26date%3D09032017%26volume%3D60%26issue%3D5%26spage%3D1843%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre V.  Ivachtchenko</span>, <span class="hlFld-ContribAuthor ">Yan  Lavrovsky</span>, and <span class="hlFld-ContribAuthor ">Yan A.  Ivanenkov</span>  . </span><span class="cited-content_cbyCitation_article-title">AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (3)
                                     , 945-963. <a href="https://doi.org/10.1021/acs.molpharmaceut.5b00830" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.5b00830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.5b00830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.5b00830%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DAVN-211%25252C%252BNovel%252Band%252BHighly%252BSelective%252B5-HT6%252BReceptor%252BSmall%252BMolecule%252BAntagonist%25252C%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DIvachtchenko%26aufirst%3DAlexandre%2BV.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D03112015%26date%3D17022016%26date%3D18122015%26date%3D26022016%26date%3D07032016%26date%3D17022016%26volume%3D13%26issue%3D3%26spage%3D945%26epage%3D963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Mar  Martín-Fontecha</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, and <span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>  . </span><span class="cited-content_cbyCitation_article-title">Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (17)
                                     , 7160-7181. <a href="https://doi.org/10.1021/jm5003952" title="DOI URL">https://doi.org/10.1021/jm5003952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5003952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5003952%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSerotonin%252B5-HT6%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDeficiency%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBenham%25C3%25BA%26aufirst%3DBellinda%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13032014%26date%3D03062014%26date%3D11092014%26date%3D21052014%26volume%3D57%26issue%3D17%26spage%3D7160%26epage%3D7181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Kucwaj-Brysz</span>, <span class="hlFld-ContribAuthor ">Hanna  Baltrukevich</span>, <span class="hlFld-ContribAuthor ">Kinga  Czarnota</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>49 </em>, 128275. <a href="https://doi.org/10.1016/j.bmcl.2021.128275" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128275%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DChemical%252Bupdate%252Bon%252Bthe%252Bpotential%252Bfor%252Bserotonin%252B5-HT6%252Band%252B5-HT7%252Breceptor%252Bagents%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKucwaj-Brysz%26aufirst%3DKatarzyna%26date%3D2021%26volume%3D49%26spage%3D128275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria P.  Giovannoni</span>, <span class="hlFld-ContribAuthor ">Niccolò  Cantini</span>, <span class="hlFld-ContribAuthor ">Letizia  Crocetti</span>, <span class="hlFld-ContribAuthor ">Gabriella  Guerrini</span>, <span class="hlFld-ContribAuthor ">Antonella  Iacovone</span>, <span class="hlFld-ContribAuthor ">Igor A.  Schepetkin</span>, <span class="hlFld-ContribAuthor ">Claudia  Vergelli</span>, <span class="hlFld-ContribAuthor ">Andrei I.  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">Mark T.  Quinn</span>. </span><span class="cited-content_cbyCitation_article-title">Further modifications of 1H‐pyrrolo[2,3‐b]pyridine derivatives as inhibitors of human neutrophil elastase. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2019,</strong> <em>15 </em><a href="https://doi.org/10.1002/ddr.21539" title="DOI URL">https://doi.org/10.1002/ddr.21539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21539%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DFurther%252Bmodifications%252Bof%252B1H%2525E2%252580%252590pyrrolo%25255B2%25252C3%2525E2%252580%252590b%25255Dpyridine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bhuman%252Bneutrophil%252Belastase%26aulast%3DGiovannoni%26aufirst%3DMaria%2BP.%26date%3D2019%26date%3D2019%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaime  Mella</span>, <span class="hlFld-ContribAuthor ">Francisco  Villegas</span>, <span class="hlFld-ContribAuthor ">César  Morales-Verdejo</span>, <span class="hlFld-ContribAuthor ">Carlos F.  Lagos</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Recabarren-Gajardo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships studies on weakly basic N -arylsulfonylindoles with an antagonistic profile in the 5-HT 6 receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1139 </em>, 362-370. <a href="https://doi.org/10.1016/j.molstruc.2017.03.067" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.03.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.03.067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DStructure-activity%252Brelationships%252Bstudies%252Bon%252Bweakly%252Bbasic%252BN%252B-arylsulfonylindoles%252Bwith%252Ban%252Bantagonistic%252Bprofile%252Bin%252Bthe%252B5-HT%252B6%252Breceptor%26aulast%3DMella%26aufirst%3DJaime%26date%3D2017%26volume%3D1139%26spage%3D362%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramakrishna  Nirogi</span>, <span class="hlFld-ContribAuthor ">Anil  Shinde</span>, <span class="hlFld-ContribAuthor ">Vinaykumar  Tiriveedhi</span>, <span class="hlFld-ContribAuthor ">Laxman  Kota</span>, <span class="hlFld-ContribAuthor ">Sangram Keshari  Saraf</span>, <span class="hlFld-ContribAuthor ">Rajesh Kumar  Badange</span>, <span class="hlFld-ContribAuthor ">Abdul Rasheed  Mohammed</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Subramanian</span>, <span class="hlFld-ContribAuthor ">Nageshwararao  Muddana</span>, <span class="hlFld-ContribAuthor ">Gopinadh  Bhyrapuneni</span>, <span class="hlFld-ContribAuthor ">Renny  Abraham</span>. </span><span class="cited-content_cbyCitation_article-title">Benzamide derivatives and their constrained analogs as histamine H 3 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 655-662. <a href="https://doi.org/10.1016/j.ejmech.2015.12.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzamide%252Bderivatives%252Band%252Btheir%252Bconstrained%252Banalogs%252Bas%252Bhistamine%252BH%252B3%252Breceptor%252Bantagonists%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2016%26volume%3D108%26spage%3D655%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradeep  Jayarajan</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Nirogi</span>, <span class="hlFld-ContribAuthor ">Anil  Shinde</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Goura</span>, <span class="hlFld-ContribAuthor ">Vuyyuru Arun  Babu</span>, <span class="hlFld-ContribAuthor ">Sumanth  Yathavakilla</span>, <span class="hlFld-ContribAuthor ">Gopinadh  Bhyrapuneni</span>. </span><span class="cited-content_cbyCitation_article-title">5-HT6 receptor antagonist attenuates the memory deficits associated with neuropathic pain and improves the efficacy of gabapentinoids. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2015,</strong> <em>67 </em>
                                    (5)
                                     , 934-942. <a href="https://doi.org/10.1016/j.pharep.2015.03.013" title="DOI URL">https://doi.org/10.1016/j.pharep.2015.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharep.2015.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharep.2015.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3D5-HT6%252Breceptor%252Bantagonist%252Battenuates%252Bthe%252Bmemory%252Bdeficits%252Bassociated%252Bwith%252Bneuropathic%252Bpain%252Band%252Bimproves%252Bthe%252Befficacy%252Bof%252Bgabapentinoids%26aulast%3DJayarajan%26aufirst%3DPradeep%26date%3D2015%26volume%3D67%26issue%3D5%26spage%3D934%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshihiko  Tashima</span>. </span><span class="cited-content_cbyCitation_article-title">Intriguing possibilities and beneficial aspects of transporter-conscious drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4119-4131. <a href="https://doi.org/10.1016/j.bmc.2015.06.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIntriguing%252Bpossibilities%252Band%252Bbeneficial%252Baspects%252Bof%252Btransporter-conscious%252Bdrug%252Bdesign%26aulast%3DTashima%26aufirst%3DToshihiko%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4119%26epage%3D4131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zengjun  Fang</span>, <span class="hlFld-ContribAuthor ">Yu’ning  Song</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Qingzhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (8)
                                     , 885-901. <a href="https://doi.org/10.4155/fmc.14.50" title="DOI URL">https://doi.org/10.4155/fmc.14.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.50%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DConformational%252Brestriction%25253A%252Ban%252Beffective%252Btactic%252Bin%252B%252527follow-on%252527-based%252Bdrug%252Bdiscovery%26aulast%3DFang%26aufirst%3DZengjun%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D885%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuanghua  Hu</span>, <span class="hlFld-ContribAuthor ">Yazhong  Huang</span>, <span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Grant-Young</span>, <span class="hlFld-ContribAuthor ">Robert L.  Bertekap</span>, <span class="hlFld-ContribAuthor ">Valerie  Whiterock</span>, <span class="hlFld-ContribAuthor ">Patrick  Brassil</span>, <span class="hlFld-ContribAuthor ">Kimberley  Lentz</span>, <span class="hlFld-ContribAuthor ">Prasanna  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">David R.  Langley</span>, <span class="hlFld-ContribAuthor ">Ryan S.  Westphal</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT6 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (5)
                                     , 1782-1790. <a href="https://doi.org/10.1016/j.bmc.2014.01.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bactivity%252Brelationship%252Bstudies%252Bof%252B3-arylsulfonyl-pyrido%25255B1%25252C2-a%25255Dpyrimidin-4-imines%252Bas%252Bpotent%252B5-HT6%252Bantagonists%26aulast%3DHu%26aufirst%3DShuanghua%26date%3D2014%26volume%3D22%26issue%3D5%26spage%3D1782%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and properties of 4-, 5-, 6- or 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (24)
                                     , 4767-4834. <a href="https://doi.org/10.1016/j.tet.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.tet.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bproperties%252Bof%252B4-%25252C%252B5-%25252C%252B6-%2525C2%2525A0or%2525C2%2525A07-azaindoles%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2013%26volume%3D69%26issue%3D24%26spage%3D4767%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported 5-HT<sub>6</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Genesis of Ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, DCM, 0–5 °C to RT, 24–48 h or DCM, pyridine, RT, 24–48 h; (b) HCl/Fe, ethanol, reflux, 2–10 h; (c) 1-methyl-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/NaH, 0–25 °C, 12–24 h, or DCM, Et<sub>3</sub>N, RT or pyridine, RT; (b) ethanol, conc HCl, reflux, 2–10 h; (c) 1-Boc-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h; (d) IPA·HCl, RT, 2–4 h; (e) 1-methyl-4-piperidone, NaBH(OAc)<sub>3</sub>, AcOH, Na<sub>2</sub>SO<sub>4</sub>, 25–30 °C, 6–24 h. For definition of Het, see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Episodic memory in adult rats for <b>12ab</b>. Data represents mean ± SEM of exploration time (Students paired <i>t</i> test, **<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Episodic memory in adult rats for <b>18c</b>. Data represents mean ± SEM of exploration time (Students paired <i>t</i> test, *<i>P</i> < 0.05, **<i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/medium/jm-2012-00955x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>18c</b> on acetylcholine modulation in medial prefrontal cortex. Data expressed mean ± SEM *<i>p</i> < 0.05, **<i>p</i> < 0.01,***<i>p</i> < 0.001 vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300955x/production/images/large/jm-2012-00955x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300955x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Alzheimer's Disease International; <a href="http://www.alz.co.uk" class="extLink">http://www.alz.co.uk</a> (accessed 11 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%27s+Disease+International%3B+http%3A%2F%2Fwww.alz.co.uk+%28accessed+11+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Disease%2520International" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, A. K.</span><span> </span><span class="NLM_article-title">Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=1555-1561&author=R.+S.+Doodyauthor=S.+H.+Ferrisauthor=S.+Sallowayauthor=Y.+Sunauthor=R.+Goldmanauthor=W.+E.+Watkinsauthor=Y.+Xuauthor=A.+K.+Murthy&title=Donepezil+treatment+of+patients+with+MCI%3A+a+48-week+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DFerris%26aufirst%3DS.%2BH.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DGoldman%26aufirst%3DR.%26aulast%3DWatkins%26aufirst%3DW.%2BE.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMurthy%26aufirst%3DA.%2BK.%26atitle%3DDonepezil%2520treatment%2520of%2520patients%2520with%2520MCI%253A%2520a%252048-week%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26spage%3D1555%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Effective Pharmacologic Management of Alzheimer’s disease</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2Fj.amjmed.2006.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=17466645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslWku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=388-397&author=M.+R.+Farlowauthor=J.+L.+Cummings&title=Effective+Pharmacologic+Management+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Pharmacologic Management of Alzheimer's Disease</span></div><div class="casAuthors">Farlow, Martin R.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">AJMEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0002-9343</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  To assist physicians in the effective pharmacol. management of this challenging population, evidence-based pharmacol. treatment algorithms for the different stages of Alzheimer's disease have been developed.  Evidence-based guidelines outlining pharmacotherapeutic strategies can be systematically implemented to optimize outcomes for patients in different stages of Alzheimer's disease.  The first step toward the best possible long-term management is early diagnosis of Alzheimer's disease, thereby facilitating early initiation of cholinesterase inhibitor treatment, which may stabilize/reduce the rate of symptomatic cognitive and functional decline.  Cholinesterase inhibitor therapy with rivastigmine, donepezil, or galantamine is endorsed as std. first-line therapy in patients with mild-to-moderate Alzheimer's disease.  The N-methyl-D-aspartate receptor-antagonist, memantine, may be used as monotherapy or in combination with a cholinesterase inhibitor for patients with moderate Alzheimer's disease, and as monotherapy for patients with severe Alzheimer's disease.  During treatment, cognitive and functional status should be monitored over 6-mo intervals, and pharmacol. therapy should ideally be continued until there are no meaningful social interactions and quality of life has irreversibly deteriorated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeKXzhxyprLLVg90H21EOLACvtfcHk0ljDD2-jtTBJSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslWku7s%253D&md5=e13b2635e1ee76f5ecbca133876da4bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2006.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2006.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DEffective%2520Pharmacologic%2520Management%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2007%26volume%3D120%26spage%3D388%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Update on the use of memantine in Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.2147%2FNDT.S4048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=19557118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSks77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=237-247&author=R.+J.+Van+Marum&title=Update+on+the+use+of+memantine+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the use of memantine in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-247</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Memantine is a low to moderate affinity N-methyl--aspartate receptor (NMDAR) antagonist.  The effects of memantine in Alzheimer's disease (AD) have been studied in 7 randomized controlled trials in many post-hoc analyses.  Three out of four RCTs in patients with moderate to severe AD (Mini Mental State Examn. [MMSE] <14) showed a statistically significant but clin. small pos. effect of memantine on cognition, global functioning, activities of daily living (ADL) and neuropsychiatric symptoms.  No effects on these outcome measures could be found in the three RCTs studying patients with mild to moderate AD (MMSE 14-24).  Two of these studies evaluated the effect of addn. of memantine to donepezil.  Only the study in patients with mild to moderate AD showed a pos. effect of addn. of memantine on cognition, ADL, global functioning and neuropsychiatric functioning.  Cost-effectiveness of memantine therapy remains controversial.  Post-hoc analyses and observational studies suggest some effects on agitation/aggression, delusions or hallucinations.  Side effects of memantine are usually mild and seem to be comparable with placebo.  In this review, an oversight of pharmacodynamics and pharmacokinetics of memantine is presented.  Also, published data concerning efficacy and safety in patients with AD are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqjRpQ6xBtbVg90H21EOLACvtfcHk0lg6zlzWRx5F0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSks77L&md5=b49108d6f4956f51f7429513a792edb8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2147%2FNDT.S4048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S4048%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DUpdate%2520on%2520the%2520use%2520of%2520memantine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2009%26volume%3D5%26spage%3D237%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sebben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansanay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptors positively coupled to adenylyl cyclase in striatal neurones in culture</span> <span class="citation_source-journal">Neuroreport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2557</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=2553-2557&author=M.+Sebbenauthor=H.+Ansanayauthor=J.+Bockaertauthor=A.+Dumuis&title=5-HT6+receptors+positively+coupled+to+adenylyl+cyclase+in+striatal+neurones+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSebben%26aufirst%3DM.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT6%2520receptors%2520positively%2520coupled%2520to%2520adenylyl%2520cyclase%2520in%2520striatal%2520neurones%2520in%2520culture%26jtitle%3DNeuroreport%26date%3D1994%26volume%3D5%26spage%3D2553%26epage%3D2557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Woolley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C. F.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=59-79&author=M.+L.+Woolleyauthor=C.+A.+Marsdenauthor=K.+C.+F.+Fone&title=5-HT6+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">5-ht6 receptors</span></div><div class="casAuthors">Woolley, Marie L.; Marsden, Charles A.; Fone, Kevin C. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-79</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-hydroxytryptamine6 (5-ht6) was 1 of the most recent addns. to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent.  The high affinity of a wide range of psychiatric drugs for the 5-ht6 receptor, together with its almost exclusive expression in the central nervous system, being abundant in limbic and cortical regions, has stimulated significant research interest.  The 5-ht6 receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures.  The current article will review all aspects of the discovery, genetics, distribution, pharmacol., and function of the 5-ht6 receptor.  Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht6 receptor to be approved and its true status recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK0SUNoG7ubVg90H21EOLACvtfcHk0lg6zlzWRx5F0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWks78%253D&md5=3883fe6d1a7764bf81a6b22e255fbf4d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoolley%26aufirst%3DM.%2BL.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%2BF.%26atitle%3D5-HT6%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2004%26volume%3D3%26spage%3D59%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span> </span><span class="NLM_article-title">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=7680751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=320-327&author=F.+J.+Monsmaauthor=Y.+Shenauthor=R.+P.+Wardauthor=M.+W.+Hamblinauthor=D.+R.+Sibley&title=Cloning+and+expression+of+a+novel+serotonin+receptor+with+high+affinity+for+tricyclic+psychotropic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs</span></div><div class="casAuthors">Monsma, Frederick J., Jr.; Shen, Yong; Ward, Raymond P.; Hamblin, Mark W.; Sibley, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-7</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The polymerase chain reaction technique was used to selectively amplify a guanine nucleotide-binding protein-coupled receptor cDNA sequence from rat striatal mRNA that exhibits high homol. to previously cloned serotonin receptors.  Sequencing of a full length clone isolated from a rat striatal cDNA library revealed an open reading frame of 1311 base pairs, encoding a 437-residue protein with 7 hydrophobic regions.  Within these hydrophobic regions, this receptor was 36-41% identical to the following serotonin (5-HT) receptors: 5-HT2 > 5-HT1D > 5-HT1C > 5-HT1B > 5-HT1A > 5-HT1E.  Northern blots revealed a ∼4.2-kilobase transcript localized in various brain regions, with the following rank order of abundance: striatum » olfactory tubercle > cerebral cortex > hippocampus.  Expression of this clone in COS-7 cells resulted in the appearance of high affinity, saturable binding of (+)-[2-125I]iodolyzergic acid diethylamide ([125I]LSD) with a Kd of 1.26 nM.  Among endogenous biogenic amines, only 5-HT completely inhibited [125I]LSD binding (Ki = 150 nM).  The inhibition of [125I]LSD binding by other serotonergic agonists and antagonists revealed a pharmacol. profile that does not correlate with that of any previously described serotonin receptor subtype.  In addn., this receptor exhibits high affinity for a no. of tricyclic antipsychotic and antidepressant drugs, including clozapine, amoxipine, and amitriptyline.  In HEK-293 cells stably transfected with this receptor, serotonin elicits a potent stimulation of adenylyl cyclase activity, which is blocked by antipsychotic and antidepressant drugs.  The distinct structural and pharmacol. properties of this receptor site indicate that it represents a completely novel subtype of serotonin receptor.  Based on its affinity for tricyclic psychotropic drugs and its localization to limbic and cortical regions of the brain, it is likely that this receptor may play a role in several neuropsychiatric disorders that involve serotonergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktsaVgvzJ9LVg90H21EOLACvtfcHk0lg6zlzWRx5F0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVWisb8%253D&md5=c8b46ab9e3591b6ea473459f18f006ea</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWard%26aufirst%3DR.%2BP.%26aulast%3DHamblin%26aufirst%3DM.%2BW.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26atitle%3DCloning%2520and%2520expression%2520of%2520a%2520novel%2520serotonin%2520receptor%2520with%2520high%2520affinity%2520for%2520tricyclic%2520psychotropic%2520drugs%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D43%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> antagonists as potential treatment for cognitive dysfunction</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=145-168&author=K.+G.+Liuauthor=A.+J.+Robichaud&title=5-HT6+antagonists+as+potential+treatment+for+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BG.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3D5-HT6%2520antagonists%2520as%2520potential%2520treatment%2520for%2520cognitive%2520dysfunction%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D145%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Witty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T. T.</span><span> </span><span class="NLM_article-title">Advances in the design of 5-HT<sub>6</sub> receptor ligands with therapeutic potential</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2FS0079-6468%2809%2904805-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=21544960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVegs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=163-224&author=D.+Wittyauthor=M.+Ahmedauthor=T.+T.+Chuang&title=Advances+in+the+design+of+5-HT6+receptor+ligands+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the design of 5-HT6 receptor ligands with therapeutic potential</span></div><div class="casAuthors">Witty, David; Ahmed, Mahmood; Chuang, Tsu Tshen</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-224</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on recent advances in the discovery, optimization and exploiting the serotonin (5-hydroxytryptamine, 5-HT) 6 receptor ligands.  The focus is on scientific publications and patent applications describing new chem. series published since 2005.  In addn. to 5-HT6 receptor modulation, approaches targeting dual 5-HT6 and second receptor modulation are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnyxjAIXLXRrVg90H21EOLACvtfcHk0ljdfPcDlJ0IXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVegs70%253D&md5=2d263999d1f49c5df128e528af4edb57</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2809%2904805-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252809%252904805-X%26sid%3Dliteratum%253Aachs%26aulast%3DWitty%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26atitle%3DAdvances%2520in%2520the%2520design%2520of%25205-HT6%2520receptor%2520ligands%2520with%2520therapeutic%2520potential%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D163%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siripurapu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolanos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">The Medicinal Chemistry of 5-HT<sub>6</sub> Receptor Ligands with a Focus on Arylsulfonyltryptamine Analogs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.2174%2F156802610791111542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=20166945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=579-595&author=R.+A.+Glennonauthor=U.+Siripurapuauthor=B.+L.+Rothauthor=R.+Kolanosauthor=M.+L.+Bondarevauthor=D.+Sikazweauthor=M.+Leeauthor=M.+Dukat&title=The+Medicinal+Chemistry+of+5-HT6+Receptor+Ligands+with+a+Focus+on+Arylsulfonyltryptamine+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs</span></div><div class="casAuthors">Glennon, Richard A.; Siripurapu, Uma; Roth, Bryan L.; Kolanos, Renata; Bondarev, Mikhail L.; Sikazwe, Donald; Lee, Mase; Dukat, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Arylsulfonyl analogs of aminopyrimidines (e.g. Ro 04-6790; 2), aminopyridines (e.g. Ro 63-0563; 3), 1-phenylpiperazines (e.g. SB-271046; 4), and tryptamines (e.g. MS-245; 5) were described as the first examples of selective 5-HT6 receptor antagonists only ten years ago.  Today, hundreds of compds. of seemingly diverse structure have been reported.  The early antagonists featured an arylsulfonyl group leading to the widespread assumption that an arylsulfonyl moiety might be crit. for binding and antagonist action.  With respect to the arylsulfonyltryptamines, it seems that neither the "arylsulfonyl" nor the "tryptamine" portion of these compds. is essential for binding or for antagonist action, and some such derivs. even display agonist action.  The present review describes many of the currently available 5-HT6 receptor ligands and, unlike prior reviews, provides a narrative of the thinking (where possible) that led to their design, synthesis, and evaluation.  The arylsulfonyltryptamines are also used as the structural basis of attempts to relate various structure-types to one another to afford a better understanding of the overall structural requirements for 5-HT6 receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcIaCOtbRK7Vg90H21EOLACvtfcHk0ljdfPcDlJ0IXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFKnur8%253D&md5=c9aac49fd24a4bc84f478db4217073d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802610791111542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791111542%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DSiripurapu%26aufirst%3DU.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKolanos%26aufirst%3DR.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3DThe%2520Medicinal%2520Chemistry%2520of%25205-HT6%2520Receptor%2520Ligands%2520with%2520a%2520Focus%2520on%2520Arylsulfonyltryptamine%2520Analogs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodgson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassam, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P.</span><span> </span><span class="NLM_article-title">5-Chloro-<i>N</i>-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon-amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT<sub>6</sub> Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980532e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=202-205&author=S.+M.+Bromidgeauthor=A.+M.+Brownauthor=S.+E.+Clarkeauthor=K.+Dodgsonauthor=T.+Gagerauthor=H.+L.+Grassamauthor=P.+M.+Jeffreyauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=D.+N.+Middlemissauthor=S.+F.+Mossauthor=H.+Newmanauthor=G.+Rileyauthor=C.+Routledgeauthor=P.+Wyman&title=5-Chloro-N-%284-methoxy-3-piperazin-1-yl-+phenyl%29-3-methyl-2-benzothiophenesulfon-amide+%28SB-271046%29%3A+A+Potent%2C+Selective%2C+and+Orally+Bioavailable+5-HT6+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm980532e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980532e%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DDodgson%26aufirst%3DK.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DGrassam%26aufirst%3DH.%2BL.%26aulast%3DJeffrey%26aufirst%3DP.%2BM.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DNewman%26aufirst%3DH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DWyman%26aufirst%3DP.%26atitle%3D5-Chloro-N-%25284-methoxy-3-piperazin-1-yl-%2520phenyl%2529-3-methyl-2-benzothiophenesulfon-amide%2520%2528SB-271046%2529%253A%2520A%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%25205-HT6%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D202%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buck, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seal, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winbornc, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, D. R.</span><span> </span><span class="NLM_article-title">Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4867-4871&author=M.+Ahmedauthor=M.+A.+Briggsauthor=S.+M.+Bromidgeauthor=T.+Buckauthor=L.+Campbellauthor=N.+J.+Deeksauthor=A.+Garnerauthor=L.+Gordonauthor=D.+W.+Hamprechtauthor=V.+Hollandauthor=C.+N.+Johnsonauthor=A.+D.+Medhurstauthor=D.+J.+Mitchellauthor=S.+F.+Mossauthor=J.+Powlesauthor=J.+T.+Sealauthor=T.+O.+Steanauthor=G.+Stempauthor=M.+Thompsonauthor=B.+Trailauthor=N.+Uptonauthor=K.+Winborncauthor=D.+R.+Witty&title=Bicyclic+heteroarylpiperazines+as+selective+brain+penetrant+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBuck%26aufirst%3DT.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DGarner%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DHamprecht%26aufirst%3DD.%2BW.%26aulast%3DHolland%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DPowles%26aufirst%3DJ.%26aulast%3DSeal%26aufirst%3DJ.%2BT.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DTrail%26aufirst%3DB.%26aulast%3DUpton%26aufirst%3DN.%26aulast%3DWinbornc%26aufirst%3DK.%26aulast%3DWitty%26aufirst%3DD.%2BR.%26atitle%3DBicyclic%2520heteroarylpiperazines%2520as%2520selective%2520brain%2520penetrant%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4867%26epage%3D4871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span>. <span class="NLM_contrib-group">Brmoidge, S. M.</span><span> </span><span class="NLM_article-title">Indolesulfonyl compounds useful in the treatment of CNS disorders</span>. WO2002041889,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.+M.+Brmoidge&title=Indolesulfonyl+compounds+useful+in+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrmoidge%26aufirst%3DS.%2BM.%26atitle%3DIndolesulfonyl%2520compounds%2520useful%2520in%2520the%2520treatment%2520of%2520CNS%2520disorders%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>GlaxoSmithKline; <a href="http://www.gsk.com" class="extLink">http://www.gsk.com</a> (accessed 11 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline%3B+http%3A%2F%2Fwww.gsk.com+%28accessed+11+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DGlaxoSmithKline" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Lundbeck; <a href="http://www.lundbeck.com/global" class="extLink">http://www.lundbeck.com/global</a> (accessed 1 June 2012).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lundbeck%3B+http%3A%2F%2Fwww.lundbeck.com%2Fglobal+%28accessed+1+June+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DLundbeck" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benny, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mads, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joanna, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soren, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mette, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louise, M. W.</span><span> </span><span class="NLM_article-title">Lu AE58054, a 5-HT<sub>6</sub> antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1017%2FS1461145710000659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=20569520" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1021-1033&author=A.+Jornauthor=B.+Bennyauthor=G.+Benauthor=P.+B.+Franklinauthor=P.+C.+Michaelauthor=W.+D.+Neilauthor=G.+Brunoauthor=K.+Madsauthor=L.+M.+Davidauthor=C.+N.+Joannaauthor=L.+N.+Davidauthor=M.+N.+Sorenauthor=N.+P.+Metteauthor=M.+S.+Johnauthor=M.+W.+Louise&title=Lu+AE58054%2C+a+5-HT6+antagonist%2C+reverses+cognitive+impairment+induced+by+subchronic+phencyclidine+in+a+novel+object+recognition+test+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000659%26sid%3Dliteratum%253Aachs%26aulast%3DJorn%26aufirst%3DA.%26aulast%3DBenny%26aufirst%3DB.%26aulast%3DBen%26aufirst%3DG.%26aulast%3DFranklin%26aufirst%3DP.%2BB.%26aulast%3DMichael%26aufirst%3DP.%2BC.%26aulast%3DNeil%26aufirst%3DW.%2BD.%26aulast%3DBruno%26aufirst%3DG.%26aulast%3DMads%26aufirst%3DK.%26aulast%3DDavid%26aufirst%3DL.%2BM.%26aulast%3DJoanna%26aufirst%3DC.%2BN.%26aulast%3DDavid%26aufirst%3DL.%2BN.%26aulast%3DSoren%26aufirst%3DM.%2BN.%26aulast%3DMette%26aufirst%3DN.%2BP.%26aulast%3DJohn%26aufirst%3DM.%2BS.%26aulast%3DLouise%26aufirst%3DM.%2BW.%26atitle%3DLu%2520AE58054%252C%2520a%25205-HT6%2520antagonist%252C%2520reverses%2520cognitive%2520impairment%2520induced%2520by%2520subchronic%2520phencyclidine%2520in%2520a%2520novel%2520object%2520recognition%2520test%2520in%2520rats%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D13%26spage%3D1021%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Nirogi, R. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daulatabad, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parandhama, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastri, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubey, P. K.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4440</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4440-4443&author=R.+V.+S.+Nirogiauthor=A.+V.+Daulatabadauthor=G.+Parandhamaauthor=S.+Mohammadauthor=K.+R.+Sastriauthor=A.+K.+Shindeauthor=P.+K.+Dubey&title=Synthesis+and+pharmacological+evaluation+of+aryl+aminosulfonamide+derivatives+as+potent+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%2BV.%2BS.%26aulast%3DDaulatabad%26aufirst%3DA.%2BV.%26aulast%3DParandhama%26aufirst%3DG.%26aulast%3DMohammad%26aufirst%3DS.%26aulast%3DSastri%26aufirst%3DK.%2BR.%26aulast%3DShinde%26aufirst%3DA.%2BK.%26aulast%3DDubey%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520aryl%2520aminosulfonamide%2520derivatives%2520as%2520potent%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4440%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhao, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethofer, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brothers, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrova, L.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzo[1,4]oxazine derivatives as 5-HT<sub>6</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3504</span><span class="NLM_x">–</span> <span class="NLM_lpage">3507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3504-3507&author=S.+H.+Zhaoauthor=J.+Bergerauthor=R.+D.+Clarkauthor=S.+G.+Sethoferauthor=N.+E.+Kraussauthor=J.+M.+Brothersauthor=R.+S.+Martinauthor=D.+L.+Misnerauthor=D.+Schwabauthor=L.+Alexandrova&title=3%2C4-Dihydro-2H-benzo%5B1%2C4%5Doxazine+derivatives+as+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%2BH.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DSethofer%26aufirst%3DS.%2BG.%26aulast%3DKrauss%26aufirst%3DN.%2BE.%26aulast%3DBrothers%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DR.%2BS.%26aulast%3DMisner%26aufirst%3DD.%2BL.%26aulast%3DSchwab%26aufirst%3DD.%26aulast%3DAlexandrova%26aufirst%3DL.%26atitle%3D3%252C4-Dihydro-2H-benzo%255B1%252C4%255Doxazine%2520derivatives%2520as%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3504%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baddeley, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khazragi, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stean, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, D. R.</span><span> </span><span class="NLM_article-title">Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5698</span><span class="NLM_x">–</span> <span class="NLM_lpage">5700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5698-5700&author=G.+Traniauthor=S.+M.+Baddeleyauthor=M.+A.+Briggsauthor=T.+T.+Chuangauthor=N.+J.+Deeksauthor=C.+N.+Johnsonauthor=A.+A.+Khazragiauthor=T.+L.+Meadauthor=A.+D.+Medhurstauthor=P.+H.+Milnerauthor=L.+P.+Quinnauthor=A.+M.+Rayauthor=D.+A.+Riversauthor=T.+O.+Steanauthor=G.+Stempauthor=B.+K.+Trailauthor=D.+R.+Witty&title=Tricyclic+azepine+derivatives+as+selective+brain+penetrant+5-HT6+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrani%26aufirst%3DG.%26aulast%3DBaddeley%26aufirst%3DS.%2BM.%26aulast%3DBriggs%26aufirst%3DM.%2BA.%26aulast%3DChuang%26aufirst%3DT.%2BT.%26aulast%3DDeeks%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DKhazragi%26aufirst%3DA.%2BA.%26aulast%3DMead%26aufirst%3DT.%2BL.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMilner%26aufirst%3DP.%2BH.%26aulast%3DQuinn%26aufirst%3DL.%2BP.%26aulast%3DRay%26aufirst%3DA.%2BM.%26aulast%3DRivers%26aufirst%3DD.%2BA.%26aulast%3DStean%26aufirst%3DT.%2BO.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DB.%2BK.%26aulast%3DWitty%26aufirst%3DD.%2BR.%26atitle%3DTricyclic%2520azepine%2520derivatives%2520as%2520selective%2520brain%2520penetrant%25205-HT6%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5698%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joiner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Routledge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafinowska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span> </span><span class="NLM_article-title">Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of <i>N</i>-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=55-58&author=S.+M.+Bromidgeauthor=S.+E.+Clarkeauthor=T.+Gagerauthor=K.+Griffithauthor=P.+Jeffreyauthor=A.+J.+Jenningsauthor=G.+F.+Joinerauthor=F.+D.+Kingauthor=P.+J.+Lovellauthor=S.+F.+Mossauthor=H.+Newmanauthor=G.+Rileyauthor=D.+Rogersauthor=C.+Routledgeauthor=H.+Serafinowskaauthor=D.+R.+Smith&title=Phenyl+benzenesulfonamides+are+novel+and+selective+5-HT6+antagonists%3A+identification+of+N-%282%2C5-dibromo-3-fluorophenyl%29-4-methoxy-3-piperazin-1-ylbenzenesulfonamide+%28SB-357134%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DClarke%26aufirst%3DS.%2BE.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DGriffith%26aufirst%3DK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoss%26aufirst%3DS.%2BF.%26aulast%3DNewman%26aufirst%3DH.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DRoutledge%26aufirst%3DC.%26aulast%3DSerafinowska%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26atitle%3DPhenyl%2520benzenesulfonamides%2520are%2520novel%2520and%2520selective%25205-HT6%2520antagonists%253A%2520identification%2520of%2520N-%25282%252C5-dibromo-3-fluorophenyl%2529-4-methoxy-3-piperazin-1-ylbenzenesulfonamide%2520%2528SB-357134%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ruth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucy, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doris, E. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chris, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, W. H.</span><span> </span><span class="NLM_article-title">Cloning of the mouse 5-HT<sub>6</sub> serotonin receptor and mutagenesis studies of the third cytoplasmic loop</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2FS0169-328X%2801%2900090-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=11406289" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=110-117&author=K.+Ruthauthor=A.+F.+Lucyauthor=E.+A.+H.+Dorisauthor=R.+G.+Chrisauthor=W.+H.+Mark&title=Cloning+of+the+mouse+5-HT6+serotonin+receptor+and+mutagenesis+studies+of+the+third+cytoplasmic+loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2801%2900090-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252801%252900090-0%26sid%3Dliteratum%253Aachs%26aulast%3DRuth%26aufirst%3DK.%26aulast%3DLucy%26aufirst%3DA.%2BF.%26aulast%3DDoris%26aufirst%3DE.%2BA.%2BH.%26aulast%3DChris%26aufirst%3DR.%2BG.%26aulast%3DMark%26aufirst%3DW.%2BH.%26atitle%3DCloning%2520of%2520the%2520mouse%25205-HT6%2520serotonin%2520receptor%2520and%2520mutagenesis%2520studies%2520of%2520the%2520third%2520cytoplasmic%2520loop%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2001%26volume%3D90%26spage%3D110%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gonzalo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elisabeth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmut, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrus, J. P.</span><span> </span><span class="NLM_article-title">Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1038%2Fsj.bjp.0706827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=16865095" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2006&pages=1133-1143&author=R.+Gonzaloauthor=S.+Elisabethauthor=P.+Martaauthor=P.+Pilarauthor=C.+Xavierauthor=H.+Jorgauthor=B.+Helmutauthor=J.+P.+Petrus&title=Efficacy+of+selective+5-HT6+receptor+ligands+determined+by+monitoring+5-HT6+receptor-mediated+cAMP+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706827%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalo%26aufirst%3DR.%26aulast%3DElisabeth%26aufirst%3DS.%26aulast%3DMarta%26aufirst%3DP.%26aulast%3DPilar%26aufirst%3DP.%26aulast%3DXavier%26aufirst%3DC.%26aulast%3DJorg%26aufirst%3DH.%26aulast%3DHelmut%26aufirst%3DB.%26aulast%3DPetrus%26aufirst%3DJ.%2BP.%26atitle%3DEfficacy%2520of%2520selective%25205-HT6%2520receptor%2520ligands%2520determined%2520by%2520monitoring%25205-HT6%2520receptor-mediated%2520cAMP%2520signaling%2520pathways%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D148%26spage%3D1133%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Anglade, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enjuanes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morillon., D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drieu la Rochelle, C.</span><span> </span><span class="NLM_article-title">The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1016%2Fj.vascn.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300955x&amp;key=16750402" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=99-105&author=V.+B.+Angladeauthor=E.+Enjuanesauthor=D.+Morillon.author=C.+Drieu+la+Rochelle&title=The+object+recognition+task+in+rats+and+mice%3A+a+simple+and+rapid+model+in+safety+pharmacology+to+detect+amnesic+properties+of+a+new+chemical+entity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DAnglade%26aufirst%3DV.%2BB.%26aulast%3DEnjuanes%26aufirst%3DE.%26aulast%3DMorillon.%26aufirst%3DD.%26aulast%3DDrieu%2Bla%2BRochelle%26aufirst%3DC.%26atitle%3DThe%2520object%2520recognition%2520task%2520in%2520rats%2520and%2520mice%253A%2520a%2520simple%2520and%2520rapid%2520model%2520in%2520safety%2520pharmacology%2520to%2520detect%2520amnesic%2520properties%2520of%2520a%2520new%2520chemical%2520entity%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Takashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryo, F.</span><span> </span><span class="NLM_article-title">Drug Induced Phospholipidosis—Pathological Aspects and its Prediction</span> <span class="citation_source-journal">J. Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1293%2Ftox.21.9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=9-24&author=N.+Takashiauthor=F.+Ryo&title=Drug+Induced+Phospholipidosis%E2%80%94Pathological+Aspects+and+its+Prediction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1293%2Ftox.21.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1293%252Ftox.21.9%26sid%3Dliteratum%253Aachs%26aulast%3DTakashi%26aufirst%3DN.%26aulast%3DRyo%26aufirst%3DF.%26atitle%3DDrug%2520Induced%2520Phospholipidosis%25E2%2580%2594Pathological%2520Aspects%2520and%2520its%2520Prediction%26jtitle%3DJ.%2520Toxicol.%2520Pathol.%26date%3D2008%26volume%3D21%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+Chemistry+of+hERG+Optimizations%3A+Highlights+and+Hang-Ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lgLxtNxxzdOxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520Chemistry%2520of%2520hERG%2520Optimizations%253A%2520Highlights%2520and%2520Hang-Ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nirogi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhyrapuneni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandikere, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benade, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muddana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irappanavar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnamaneni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkanti, K.</span><span> </span><span class="NLM_article-title">Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm300955x&amp;key=10.1007%2Fs13318-012-0081-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300955x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Omur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=155-161&author=R.+Nirogiauthor=G.+Bhyrapuneniauthor=V.+Kandikereauthor=V.+Benadeauthor=N.+Muddanaauthor=R.+Saralayaauthor=S.+Irappanavarauthor=R.+Ponnamaneniauthor=K.+Mukkanti&title=Concurrent+administration+of+atypical+antipsychotics+and+donepezil%3A+drug+interaction+study+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats</span></div><div class="casAuthors">Nirogi, Ramakrishna; Bhyrapuneni, Gopinadh; Kandikere, Vishwottam; Benade, Vijay; Muddana, Nageswararao; Saralaya, Ramanatha; Irappanavar, Shantaveer; Ponnamaneni, Ranjithkumar; Mukkanti, K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-161</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Springer France</span>)
        </div><div class="casAbstract">Psychotic and behavioral symptoms are common in patients with dementia.  Thus, it is rational to assume that patients with dementia would gain benefit from combination therapy of an antipsychotic agent and a cognitive enhancer.  Antipsychotics are not approved by the US FDA in elderly patients with dementia but their use is still prevalent in other population.  In the current study, we investigate the effect of atypical antipsychotics on acetylcholine modulation by donepezil.  In addn., the plasma pharmacokinetics on concurrent administration of these drugs was studied.  Acetylcholine modulation was carried out in the ventral hippocampus of Sprague-Dawley rats using brain microdialysis technique.  In a parallel group of animals, pharmacokinetic parameters were evaluated on administration of donepezil (5.0 mg kg-1, i.p.) alone and in combination with olanzapine, clozapine, or quetiapine.  Donepezil produced 348% increase in hippocampal acetylcholine levels.  Coadministration of olanzapine and donepezil produced 393% increase in extracellular acetylcholine, and the effect was supported by a significantly (p < 0.05) decreased clearance of donepezil in plasma.  Whereas, other plasma pharmacokinetic parameters of donepezil "AUC0-24h, T 1/2 and T max" were moderately altered after this combination treatment.  Concurrent administrations of clozapine or quetiapine with donepezil produced a non-significant change in acetylcholine levels in comparison to donepezil alone.  The plasma pharmacokinetics of donepezil was unaltered.  Results from this preclin. investigation indicate that extrapyramidal side effects may ppt. upon coadministration of donepezil with olanzapine.  Care must be exercised by physicians and caregivers while administering these two drugs together.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXWjvJN-HlrVg90H21EOLACvtfcHk0lgLxtNxxzdOxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Omur7J&md5=5c2d688bed1f49ea55d655e2b2521379</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs13318-012-0081-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13318-012-0081-1%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DIrappanavar%26aufirst%3DS.%26aulast%3DPonnamaneni%26aufirst%3DR.%26aulast%3DMukkanti%26aufirst%3DK.%26atitle%3DConcurrent%2520administration%2520of%2520atypical%2520antipsychotics%2520and%2520donepezil%253A%2520drug%2520interaction%2520study%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2012%26volume%3D37%26spage%3D155%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Paxinos, G.; Watson, C.</span> In  <span class="citation_source-book">Rat Brain in Stereotaxic Coordinates</span>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Paxinos&author=C.+Watson&title=Rat+Brain+in+Stereotaxic+Coordinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaxinos%26aufirst%3DG.%26btitle%3DRat%2520Brain%2520in%2520Stereotaxic%2520Coordinates%26pub%3DAcademic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Batcho, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimgruber, W.</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Batcho%2C+A.+D.%3B+Leimgruber%2C+W.Org.+Synth.+1985%2C+63%2C+214%E2%80%93220"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatcho%26aufirst%3DA.%2BD.%26aulast%3DLeimgruber%26aufirst%3DW.%26jtitle%3DOrg.%2520Synth.%26date%3D1985%26volume%3D63%26spage%3D214%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">An effective procedure for the preparation of 3-substituted-4- or 6-azaindoles from <i>ortho</i>-methyl nitro pyridines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=5653-5656&author=J.+Zhuauthor=H.+Wongauthor=Z.+Zhangauthor=Z.+Yinauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=An+effective+procedure+for+the+preparation+of+3-substituted-4-+or+6-azaindoles+from+ortho-methyl+nitro+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DAn%2520effective%2520procedure%2520for%2520the%2520preparation%2520of%25203-substituted-4-%2520or%25206-azaindoles%2520from%2520ortho-methyl%2520nitro%2520pyridines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span>. <span class="NLM_contrib-group">Bonhaus, D. W.; Martin, R. S.; Sethofer, S.; Zhang, L.; Zhao, S.</span><span> </span><span class="NLM_article-title">Benzoxazine and quinoxaline derivatives and uses</span>. WO 2006037481 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=D.+W.+Bonhaus&author=R.+S.+Martin&author=S.+Sethofer&author=L.+Zhang&author=S.+Zhao&title=Benzoxazine+and+quinoxaline+derivatives+and+uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26atitle%3DBenzoxazine%2520and%2520quinoxaline%2520derivatives%2520and%2520uses%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i78"><a href="/doi/suppl/10.1021/jm300955x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32172"></div></div></div></div></div><hr /></hr><p class="last">Experimental protocols for the determination of <i>K</i><sub>b</sub> values for 5-HT<sub>6</sub> receptor, dofetilide binding hERG assay, microsomal metabolic and CYP 3A4 and 2D6 inhibition protocol, pharmacokinetic study in rats and dogs, rodent brain penetration study, in vivo brain microdialysis and object recognition task. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300955x/suppl_file/jm300955x_si_001.pdf">jm300955x_si_001.pdf (142.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300955x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm300955x%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300955x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679946852e8b223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
